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ABSTRACT
Elucidating biomolecular interactions that underlie the cellular processes vital to
the survival and infectivity of the parasitic protozoan Toxoplasma gondii is crucial for
development of effective prophylactics and therapeutics against this resilient pathogen. In
the first two parts of this three-part study, the significance of protein-protein, proteinnucleic acid, and protein-lipid interactions in T. gondii pathogenicity is explored. The
first part of the study presents an overview of current knowledge on the topic of liquidliquid phase separation, which is the condensation of macromolecules driven by
multivalent interactions between protein and protein or protein and nucleic acids, and its
multifaceted role in the proliferation and survival of pathogens such as T. gondii. The
second part of the study investigates the influence of the T. gondii small ubiquitin-like
modifier (TgSUMO) peptide on protein-lipid interaction using model membranes. In
vitro studies with recombinant TgSUMO and giant unilamellar vesicles revealed the
following: 1) the presence of weak, non-covalent interactions between TgSUMO and the
artificial membrane, and 2) TgSUMO does not exhibit lipid bilayer phase preference and
associates equally with liquid-ordered (lo) and liquid-disordered (ld) phases. The third part
of the study describes the establishment of an inducible CRISPR interference system in T.
gondii for gene function studies. Upon examining multiple factors that influence
CRISPRi efficiency, it was found that induction of dCas9 transcription at 16 hours postinfection with 3.0 μg/mL anhydrotetracycline yielded a 15% reduction of gene expression,
which is the highest knockdown efficiency observed in this study. This relatively low
knockdown efficiency indicates that further optimization of the current CRISPRi system
in T. gondii is necessary for it to be used for loss-of-function studies.
IV
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CHAPTER ONE
General Introduction

This thesis is comprised of three main chapters that describes three separate,
standalone projects that were completed throughout the duration of this Master’s program.
The first chapter is a literature review on the topic of liquid-liquid phase separation
(LLPS), with a focus on how LLPS is utilized or manipulated by pathogens to facilitate
successful infection as well as survival within their hosts. The literature review first
provides the reader a summary of current knowledge on the driving forces of LLPS, the
factors that influence or govern LLPS, existing techniques commonly used by researchers
to study phase-separated structures, and the roles of LLPS in cell physiology. The latter
half of the literature review discusses the different mechanisms that pathogens including
Toxoplasma gondii utilize to exploit LLPS in favour of their survival and proliferation,
which includes forming phase-separated structures to 1) accelerate replication, 2)
sequester host immune factors, and 3) enable survival in unfavourable conditions for
growth. Pathogens may also facilitate the disruption of host phase-separated structures to
evade elimination by the host immune system. The second chapter of this thesis presents
the research study on the investigation of Toxoplasma gondii small ubiquitin-like
modifier (TgSUMO) peptide and its influence on protein-lipid interaction. In this study,
model membranes synthesized from pure lipids (GUVs) and derived from mammalian
cells (GPMVs) were utilized to examine the interaction between TgSUMO and the
membrane surface. Additionally, the phase preference of TgSUMO was also investigated
using model membranes to determine whether TgSUMO could influence the partitioning
of its substrates into liquid-ordered (lo) and liquid-disordered (ld) phases. Lastly, the third
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chapter of this thesis presents the research study on establishing an inducible
CRISPR/dCas9 (CRISPRi) system to facilitate efficient gene repression in Toxoplasma
gondii. In this study, a plasmid containing a tetracycline-inducible dCas9-KRAB derived
from Streptococcus pyogenes and a single guide RNA under a strong U6 promoter were
constructed and introduced into a tetracycline repressor-producing strain of T. gondii. To
test the constructed CRISPRi system and its efficacy in downregulating gene expression,
a transgenic line of T. gondii expressing green fluorescent protein (GFP) was created and
used with the engineered CRISPRi system specific to the promoter controlling GFP
expression. Multiple parameters such as induction periods, inducer concentration, and
single guide RNA target positions were scrutinized and altered to optimize knockdown
efficiency.
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CHAPTER TWO
Principles of Liquid-Liquid Phase Separation and
Its Role in Mediating Pathogen Infection and Survival

This chapter is a literature review on the topic of liquid-liquid phase separation
with a focus on its role in pathogen infection and survival within the host milieu or in the
extracellular environment. The first half of the literature review summarizes the
underlying mechanisms and factors governing liquid-liquid phase separation, the
techniques used to study the formation and properties of phase-separated structures, and
the functional roles of biomolecular condensates in cell physiology. The second half of
the literature review presents an overview of current knowledge on how infectious agents
such as viruses, bacteria, fungi, and parasites utilize or manipulate phase-separated
structures to facilitate their replication and propagation, antagonize host immune defense,
and survive in unfavourable conditions.

2.1. Liquid-Liquid Phase Separation
The formation of membraneless organelles remained elusive for many years until
recent studies of nucleoli and ribonucleoprotein granules revealed behaviours
characteristic of fluids such as flowing, dripping, and fusion in addition to appearances
akin to liquid droplets (Brangwynne et al., 2009; Brangwynne et al., 2011; Wippich et al.,
2013; Patel et al., 2015). It became clear that the formation of these membraneless
organelles, or biomolecular condensates, is facilitated by a process called liquid-liquid
phase separation (LLPS). Studies have alluded weak multivalent interactions between
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protein and protein or protein and nucleic acid as the driving force behind LLPS (Li et al.,
2012, Aumiller et al., 2016; Du & Chen, 2018). Proteins that possess tandem arrays of
folded domains constitute one category of proteins that can undergo LLPS. The most
well-known example is the condensation of proteins containing repeats of the Src
homology 3 (SH3) domain with proteins containing repeats of the proline-rich motif
(PRM) (Li et al., 2012). It was alluded that multivalent interactions between the polySH3 domains and poly-PRM ligands in the engineered proteins drove the formation of
phase-separated droplets in vitro. Additionally, a study conducted by Su et al. (2016)
demonstrated that both of the SH3 domains in the growth factor receptor-bound protein 2
(Grb2) protein were required for phase separation of Grb2 with linker for activation of T
cells (LAT) and Son of sevenless 1 (Sos1). Multivalent interactions between different
types of folded domains in synaptic Ras GTPase-activating protein (SynGAP) and
postsynaptic density protein 95 (PSD95) also lead to phase separation of the SynGAPPSD95 complex (Zeng et al., 2016). Intrinsically disordered proteins containing stretches
of sequences with limited amino acid diversity, also known as low-complexity regions
(LCRs), constitute the second category of proteins that can undergo LLPS. A notable
example is the RNA-binding protein fused in sarcoma (FUS), whose N-terminal LCR has
been shown in numerous studies to mediate the formation of phase-separated hydrogel
droplets (Kato et al., 2012; Han et al., 2012; Burke et al., 2015; Murakami et al., 2015;
Patel et al., 2015). Other LCR-containing proteins that phase separate include
heterogeneous nuclear ribonucleoprotein A1 and A2 (hnRNPA1 & hnRNPA2), TAR
DNA binding protein 43 (TDP-43), T-cell-restricted intracellular antigen 1 (TIA-1),
LAF-1, and DEAD-Box Helicase 4 (Ddx4) (Molliex et al., 2015; Ryan et al., 2018;
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Conicella et al., 2016; Mackenzie et al., 2017; Elbaum-Garfinkle et al., 2015; Nott et al.,
2015). The LCRs of phase-separating proteins are often enriched in glycine and polar
amino acids (serine, glutamine, asparagine) with aromatic (phenylalanine and tyrosine)
and charged (arginine and lysine) residues interspersed between them (Kato et al., 2012;
Han et al., 2012; Burke et al., 2015; Elbaum-Garfinkle et al., 2015; Lin et al., 2015;
Molliex et al., 2015; Riback et al., 2017). The arrangement of amino acids in LCRs are
quite deliberate rather than randomly dispersed throughout the region. LCRs tend to
contain repeats of short sequences such as [G/S]-[F/Y]-[G/S], FG, RG/RGG, SY, polyQ
and polyN, as well as blocks of charged amino acids (Kato et al., 2012; Nott et al., 2015;
Brangwynne et al., 2015; Pak et al., 2016; Li et al., 2018; Langdon et al., 2018). Such
arrangement of amino acids is thought to promote phase separation through electrostatic,
cation-π, π-π, and dipole-dipole interactions between the side chains (Nott et al., 2015;
Pak et al., 2016; Boeynaems et al., 2017; Monahan et al., 2017; Murray et al., 2017;
Qamar et al., 2018). The importance of LCRs in phase separation is apparent when
mutations in LCRs abolish the ability of the proteins to undergo LLPS or induce aberrant
liquid-to-solid phase transitions that are often associated with development of diseases
(Nott et al., 2015; Conicella et al., 2016; Kim et al., 2013; Murakami et al., 2015; Patel et
al., 2015; Mackenzie et al., 2017; Ryan et al., 2018). While majority of the molecules
reported to phase separate are proteins, RNA can also undergo LLPS by itself to form
liquid compartments. Specifically, RNA molecules enriched in nucleotide repeats tend to
coalesce into gel-like condensates as a result of multivalent base-pairing (Jain & Vale,
2017).
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2.2. Factors Governing Liquid-Liquid Phase Separation
The formation of membraneless organelles and their phase behaviour is not only
modulated by multivalent macromolecules, they are also governed by a variety of factors
that dictate the physical properties and dynamics of condensates by influencing
multivalent interactions between the phase-separating macromolecules. In this section, I
discuss some of the key regulators of LLPS and how they act to promote or inhibit the
formation of biomolecular condensates.
2.2.1. The Multifaceted Role of RNA in LLPS
Since many membraneless organelles in the cell are involved in RNA metabolism
and the majority of proteins identified to undergo LLPS are RNA-binding proteins, it is
not surprising that RNA has a significant role in influencing the assembly or integrity of
liquid condensates. It has been demonstrated in multiple studies that RNA promotes
LLPS of LCR-containing proteins (Li et al., 2012; Burke et al., 2015; Lin et al., 2015;
Zhang et al., 2015). In the case of RNA-binding proteins such as Whi3, the multivalent
interaction between the RNA molecule and the protein’s RNA recognition motif (RRM)
mediates the formation of phase-separated droplets (Zhang et al., 2015). Some RNAs
contain modular domains that are required for assembly of membraneless organelles. For
example, the middle domain of the architectural long non-coding RNA nuclear enriched
abundant transcript 1 isoform 2 (NEAT1_2) is essential for formation of paraspeckles
(Yamazaki et al., 2018). Although RNA overall promotes formation of phase-separated
structures, it can also inhibit their assembly at high concentrations (Burke et al., 2015;
Zhang et al., 2015). The concentration of RNA can influence the physical properties of
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the condensates, although its effects vary depending on the features of the RNA and/or
protein. For example, it was found that increased concentrations of RNA resulted in
decreased viscosity and thus increased fluidity of the LAF-1 droplet, but the opposite
phenomenon is observed in Whi3 where increased RNA concentration resulted in
increased viscosity and thus decreased fluidity of the Whi3 droplet (Elbaum-Garfinkle et
al., 2015; Zhang et al., 2015). Since the RNA used in these two studies are different in
length and sequence composition, it is thought that different RNA species may give rise
to condensates with different biophysical properties. This idea is supported by a study
conducted by Zhang et al. (2015) where it was observed that two different mRNAs, the
cyclin transcript CLN3 and the formin transcript BNI1, generated Whi3 droplets that
exhibited different viscoelastic properties. RNA not only governs the formation and
physical properties of phase-separated structures; it is also the principal determinant of
droplet identity. Recent work conducted by Langdon et al. (2018) demonstrated that the
secondary structure of RNAs facilitates their self-assembly and is responsible for
dictating what components can be recruited into or excluded from the compartment. This
finding revealed that RNA had a more active role in LLPS than previously thought and
provided further insights into the underlying mechanisms of condensate formation and
maintenance.
2.2.2. Post-Translational Modifications as Key Regulators of LLPS
The ability of post-translational modifications (PTMs) to either promote or disrupt
the formation of condensates by strengthening or weakening multivalent interactions
between the phase-separated biomolecules makes them important regulators of LLPS.
For example, SUMOylation of the RNA-binding protein SOP-2 induces its LLPS (Qu et
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al., 2020). Acetylation of the lysine residue in TDP-43’s RRM has also been shown to
trigger phase-separation of TDP-43 (Morato et al., 2020). On the other hand, arginine
methylation of Ddx4, FUS, and hnRNPA2 disrupts phase-separated structures by
reducing cation-π interactions between the arginine in RGG/RG motifs and aromatic
residues such as tyrosine or phenylalanine (Nott et al., 2015; Hofweber et al., 2018;
Qamar et al., 2018; Ryan et al., 2018). Arginine methylation of ubiquitin-associated
protein 2-like (UBAP2L), a protein involved in stress granule formation, also results in
inhibition of stress granule assembly (Huang et al., 2020). While arginine methylation is
commonly associated with repression of phase separation, it can also promote assembly
of membraneless organelles. For example, methylation of arginines in the RGG domain
of the RNA-binding protein Lsm4 has been shown to stimulate formation of processing
bodies (Arribas-Layton et al., 2016). Phosphorylation of the LCRs in FUS by DNAdependent protein kinase (DNA-PK) reduces phase separation and prevents self-assembly
of FUS via its LCRs (Han et al., 2012; Monahan et al., 2017; Murray et al., 2017).
Phosphorylation’s effect on phase separation is not only suppressive, as it can also induce
the formation of tau-containing condensates (Ambadipudi et al., 2017; Wegmann et al.,
2018). An excess or lack of post-translational modifications such as hypomethylation or
hyperphosphorylation of proteins that undergo LLPS is known to contribute to
pathogenesis of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s
disease (Hofweber et al., 2018; Qamar et al., 2018; Wegmann et al., 2018).
2.2.3. Environmental Factors and Their Effects on LLPS
In addition to RNA and PTMs, environmental factors can also influence the
formation of phase-separated structures and their stability. For example, numerous
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studies have demonstrated the effects of salt on LLPS. Low salt concentration was found
to promote the formation of phase-separated droplets (Elbaum-Garfinkle et al., 2015; Lin
et al., 2015; Zhang et al., 2015). As the salt concentration increases, the droplets become
less stable as salt interrupts the electrostatic interactions formed between the protein
molecules (Nott et al., 2015; Lin et al., 2015). Phase-separated structures are also
sensitive to fluctuations in temperature and tonicity, as liquid compartments formed from
LLPS were found to dissociate with increasing temperature and upon osmotic shock
(Nott et al., 2015). Additionally, pH was shown to modulate phase separation of the
budding yeast translation termination factor Sup35, as low pH induced the assembly of
Sup35 into liquid condensates that subsequently transitions into gel-like states
(Franzmann et al., 2018). Lastly, many studies have suggested that molecular crowding
promotes protein phase separation, as the use of crowding agents reduced the protein
concentration required for LLPS (André & Spruijt, 2020). However, the exact
mechanisms of how crowding agents such as polyethylene glycol and dextran enhance
LLPS still remain to be elucidated.

2.3. Current Tools and Techniques for Studying Liquid-Liquid Phase Separation
In-depth characterization of biomolecular condensates’ morphology, dynamics,
and structures is essential to better understand the role of LLPS in cell physiology and
diseases. This section highlights some of the most commonly used techniques for
studying phase-separated structures and their specific applications. For an extensive
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review of all the methods employed in characterization of liquid compartments, I direct
readers to a recent review by Mitrea et al. (2018).
2.3.1. Microscopy-Based Methods
Contrast-based microscopy techniques such as differential interference contrast
(DIC) is widely utilized for direct observations of liquid droplets and solid aggregates
such as fibrils that formed from phase-separated proteins (Li et al., 2012; Ambadipudi et
al., 2017; Mackenzie et al., 2017; Murray et al., 2017; Ryan et al., 2018). DIC enhances
contrast in transparent and unstained structures by exploiting the differences in refractive
indices associated with different parts of the specimen, which generates phase variations
in the diffracted light beams (Murphy, 2001). These phase differences are then translated
into intensity variances that can be detected and measured. DIC has been used
extensively to detect coexistence of separate phases, condensate morphology, and fusion
and fission events (Burke et al., 2015; Conicella et al., 2016; Brangwynne et al., 2011;
Molliex et al., 2015; Ambadipudi et al., 2017). Such contrast-based imaging system is a
popular choice for visualization of phase-separated structures, as it emphasizes
boundaries of liquid compartments and reveals fine microscopic details of biomolecular
condensates (Frohlich, 2008). While DIC itself is quite useful in observations of phaseseparated structures, many studies also employ fluorescence microscopy in addition to
DIC to visualize liquid condensates. Fluorescence microscopy works by exciting the
fluorophores in the specimen with a laser tuned to a specific wavelength, followed by
emission of light at a different wavelength by the fluorophores (Sanderson et al., 2014).
Fluorescence microscopy has become a staple in LLPS studies as it allows for
components of interest to be selectively tracked and is especially useful when monitoring
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interactions and localizations of multiple biomolecules or liquid compartments. For
example, Zhang et al. (2015) utilized Cy3-labelled CLN3 mRNAs and GFP-tagged Whi3
proteins to visualize the effects of RNA on poly-Q protein phase separation.
Fluorescently-labelled RNAs (BNI1, CLN3, SPA2) and Whi3 have also been used to
monitor the recruitment of SPA2 but not CLN3 into Whi3-BNI droplets (Langdon et al.,
2018). The coexistence of multiple sub-compartments within the nucleolus can be
observed with the use of fluorescence microscopy as well (Feric et al., 2016). The
measurement of fluorescence intensity also provides a means of estimating protein
concentrations in the condensed droplets (Zeng et al., 2018). As convenient and useful as
fluorescence microscopy is, the conjugation of fluorophores may run the risk of
potentially altering protein and nucleic acid properties and impacting their abilities to
phase separate. Therefore, caution must be exercised when investigating phase behaviour
of proteins tagged with fluorescent probes. Fluorescence recovery after photobleaching
(FRAP) is another important technique consistently utilized in the study of LLPS that
involves fluorophores. FRAP takes advantage of the photobleaching phenomenon, where
fluorophores lose their ability to fluoresce after accumulating damage from exposure to
light, to study dynamics of biomolecules within the cell (Ishikawa-Ankerhold et al.,
2012). In FRAP, fluorophores in a region of interest (ROI) are subjected to illumination
using a high intensity laser, and the bleached ROI is subsequently monitored for changes
in fluorescence intensity caused by the diffusion of unbleached fluorescent molecules
into the bleached ROI (Ishikawa-Ankerhold et al., 2012; De Los Santos et al., 2015).
FRAP is commonly applied to evaluate the mobility and diffusivity of proteins and RNAs
within the condensate or between the dense phase and the surrounding dilute phase (Li et
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al., 2012; Elbaum Garfinkle et al., 2015; Molliex et al., 2015; Nott et al., 2015; Aumiller
et al., 2016). FRAP analyses can reveal liquid-like behaviours and physical properties of
biomolecules condensates and detect changes in molecular dynamics within the droplet
that are induced by RNA or other factors, making it a popular technique to study LLPS.
2.3.2. Scattering Methods
In addition to microscopy, scattering techniques are also routinely used in LLPS
studies. For example, turbidity measurements are commonly employed to detect LLPS
threshold concentration in a solution and to evaluate effects of salt, RNA, and pH on
phase separation (Lin et al., 2017; Babinchak et al., 2019; Xue et al., 2019; Perdikari et
al., 2020). Turbidity is measured by illuminating the solution with a beam of light at a
wavelength outside of a protein’s absorbance range (~350 nm to 650 nm) and detecting
the intensity of scattered light (Raut & Kalonia, 2016). Many studies enlist dynamic light
scattering (DLS) to analyze size of particles in suspension and detect self-assembly of
macromolecules. DLS measures the fluctuations in light scatter intensities over time
caused by Brownian motion of particles, or random movements of particles as a result of
collision with other solvent molecules (Nimesh, 2013). The variations in scatter
intensities contain information about the rate of Brownian motion, and this can be used to
calculate the particle’s hydrodynamic size using the Einstein-Stokes equation (Stetefeld
et al., 2016). DLS has been used to identify salt-induced oligomerization of low
complexity domains (LCDs) of TDP-43 (Babinchak et al., 2019). In addition, the
promotion of Pab1 and proline-arginine peptide phase separation by physiological stress
and RNA was demonstrated by detecting size growth of these liquid droplets using DLS
(Boeynaems et al., 2017; Riback et al., 2017). Small angle X-ray scattering (SAXS) is
12

often used in conjunction with DLS to extract size and shape information of
macromolecules in solution. In SAXS, the sample is illuminated by a monochromatic
beam of X-ray, and the intensities of X-rays scattered at small angles (0-5°) are recorded
by a detector (Choi & Morais, 2014; Bolden et al., 2015). The scattering intensity (I(q)) is
expressed as a function of scattering angles, which is often converted into momentum
transfer (q) (Liu & Zwart, 2012). From the scatter profile, a wealth of information such as
particle shape, surface to volume ratio, and size can be extracted (Bolden et al., 2015).
SAXS data were used to detect the oligomerization of poly SH3 domain proteins with
poly proline-rich PRM ligands, which indicated that LLPS is driven by multivalent
interactions between proteins with folded domains (Li et al., 2012). The structural
information regarding the LCD of the poly-A binding protein Pab1 provided by SAXS
revealed the importance of hydrophobically-mediated low complexity domain
compactness in promoting phase separation (Riback et al., 2017). The kinetics of LLPS in
protein solutions with a lower critical solution temperature (LCST) phase behavior have
also been studied using ultra small angle X-ray and neutron scattering (USAXS &
VSANS) (Da Vela et al., 2016). Scattering techniques are generally non-invasive and
require little amount of sample for measurements, making them an attractive choice for
studying phase-separated structures (Choi & Morais, 2014; Stetefeld et al., 2016;
Welborn & Detsi, 2020).
2.3.3. Nuclear Magnetic Resonance
Nuclear magnetic resonance (NMR) spectroscopy is widely incorporated into the
study of LLPS for structural characterization of phase-separated proteins. In NMR
spectroscopy, nuclei with a non-zero spin in a strong magnetic field are excited from a
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low energy state to a high energy state by absorbing radio-frequency radiation, and when
this state transition occurs the nuclei are considered to be in resonance with the magnetic
field (Tanzi et al., 2019). The absorption of energy by the nuclei is measured in the form
of a resonance signal and this can reveal local information about the chemical
environment of the nuclei. The resonant frequency of the energy absorbed by nuclei can
be affected by electron shielding, which depends on the nuclei’s chemical environment
(Chatham & Blackband, 2001). Therefore, nuclei in different chemical groups will have
different resonant frequencies and this is how chemical composition can be deduced from
NMR spectra. Due to the lack of permanent secondary and tertiary structures of proteins
with LCDs, it is difficult to apply X-ray crystallography to study LCD structures as their
disordered conformations impede the formation of crystals (Mier et al., 2020). NMR
spectroscopy, on the other hand, does not require crystallization of proteins which makes
it more suitable for structural analysis of LCDs. For example, NMR spectroscopy
analysis revealed that the low complexity regions of FUS, tau, and hnRNPA2 remained
in a disordered conformation while engaging in multivalent interactions (Burke et al.,
2015; Ambadipudi et al., 2017; Ryan et al., 2018). From NMR spectroscopy data, it was
found that the self-assembly of the α-helical element in TDP-43’s C-terminal domain is
enhanced by one tryptophan residue in the α-helix, and that tryptophan residue is
important for LLPS of TDP-43 (Li et al., 2018). Post-translational modification sites in
low complexity regions of FUS and hnRNPA2 were also identified with the use of NMR
spectroscopy (Monahan et al., 2017; Ryan et al., 2018). NMR spectroscopy is noninvasive just like scattering techniques and it is especially useful in LLPS studies in the

14

sense that it can provide important structural information about LCD-containing proteins
that other techniques like X-ray crystallography cannot (Chatham & Blackband, 2001).

2.4. Functional Roles of Liquid-Liquid Phase Separation in Cell Physiology
Structures formed from LLPS have a myriad of functions within the cell. For
instance, they are capable of sensing changes in the cellular environment and respond
accordingly by modifying their morphology (Riback et al., 2017; Franzmann et al., 2018).
Due to the transient, reversible, and dynamic nature of these liquid-like assemblies, it is
no surprise that membraneless organelles are involved in the stress response (Van
Leeuwen & Rabouille, 2019). The lack of membrane barrier also enables condensates to
alter their internal composition rapidly by exchanging components with the surrounding
cytoplasm in response to environmental cues. LLPS can promote the activation of
biochemical reactions and cellular processes or increase their efficiencies by
concentrating specific molecules together. For example, the phase separation of miRNAinduced silencing complex (miRISC) enabled sequestration of miRNA targets and
accelerated deadenylation of target RNAs (Sheu-Gruttadauria & MacRae, 2018). The
localization and concentration of target RNAs with RNA degradation factors via LLPS
allowed for RNA metabolism to occur in an efficient manner. LLPS of cyclic GMP-AMP
synthase (cGAS) and DNA was also shown to significantly augment the production of
cyclic GMP-AMP (cGAMP) by cGAS, as concentrating reactants with enzymes in these
liquid condensates promoted the catalysis of cGAMP synthesis (Du & Chen, 2018).
Concentration of molecules to initiate or accelerate reaction via LLPS is quite common in
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the cell, as many cellular processes such as transcription activation and DNA repair are
reliant on formation of liquid compartments for these processes to proceed in a specific
and efficient manner (Lu et al., 2020; Oshidari et al., 2020). The opposite may also occur
where phase-separated condensates sequester certain molecules to inhibit or inactivate
reactions. For instance, the target of rapamycin complex 1 (TORC1) was found to be
sequestered into stress granules to impede the activation of nutrient-induced TORC1
signaling pathway and inhibit protein synthesis when the cell is under heat stress
(Takahara & Maeda, 2012; Wippich et al., 2013). Additionally, LLPS-formed structures
can serve as molecular filters that are able to exclude certain components but retain others.
For instance, the DEAD-box helicase Ddx4 condensate was found to exclude doublestranded DNA/RNA yet preserve single-stranded DNA/RNA and proteins with high
arginine content (Nott et al., 2015; Nott et al., 2016). Many of the functional roles
associated with liquid compartments discussed above are also observed in biomolecular
condensates formed by pathogens to aid in their propagation and infection, which will be
discussed in more detail in the subsequent sections.

2.5. Liquid-Liquid Phase Separation in Pathogen Infections
In the recent years, great effort has been made by the scientific community to
elucidate the role of LLPS in the pathogenesis of neurodegenerative disorders and cancer
for development of effective therapeutics (Alberti & Dormann, 2019). However, the
involvement of LLPS has yet to be extensively characterized in infectious diseases. There
is now growing evidence indicating pathogenic organisms utilize LLPS for efficient
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replication, evasion from host immune detection, and survival in host milieu. In this
section, I discuss how various infectious agents such as viruses, bacteria, and parasites
exploit LLPS to facilitate their infection and antagonize host immune responses.
2.5.1. Pathogen-Formed Membraneless Compartments and Their Roles in
Infection
2.5.1.1. Viral Inclusion Bodies as Sites of Replication, Transcription & Assembly
Studies have indicated that many negative-strand RNA viruses tend to form
membraneless compartments termed inclusion bodies (IBs) or viroplasms in the host
cytoplasm upon infection (Lahaye et al., 2009; Hoenen et al., 2012; Rincheval et al.,
2017). These IBs are enriched in viral genomic RNA and proteins involved in RNA
synthesis, which led researchers to speculate and later confirm their functions as
specialized transcription and replication sites (Figure 2.1A). Although viral
membraneless cytoplasmic inclusions are widely observed in virus-infected cells, the
underlying mechanisms of their formation remained unknown up until recently.
Increasingly more studies have now demonstrated that viral replication compartments
display behaviours and properties characteristic of liquid condensates such as droplet
fusion, assumption of a spherical shape due to surface tension, and rapid exchange of
molecules between the compartment and the cytoplasm (Nikolic et al., 2017; Heinrich et
al., 2018; Zhou et al., 2019). These liquid-like behaviours exhibited by the viral IBs
indicate LLPS is the driving force behind the formation of viral replication and
transcription sites. Table 2.1 provides a summary of LLPS-formed structures identified
in viruses, the proteins that make up these liquid condensates, as well as their role in
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infection. Viral proteins involved in RNA synthesis such as nucleocapsid protein (N) and
phosphoprotein (P) possess domains with high levels of intrinsic disorder, which are
known to mediate LLPS by participating in weak multivalent interactions (Longhi et al.,
2003; Gerard et al., 2009; Jensen et al., 2011; Pereira et al., 2017; Milles et al., 2018). It
has been demonstrated in numerous studies that the N and P proteins of viruses in the
Mononegavirales order such as measles virus (MeV), rabies virus (RABV), vesicular
stomatitis virus (VSV), and human metapneumovirus (HMPV) are necessary for
formation of viral replication and transcription sites (Nikolic et al., 2017; Heinrich et al.,
2018; Zhou et al., 2019; Guseva et al., 2020; Cifuentes-Muñoz et al., 2017; Thompson et
al., 2019). In positive-sense RNA viruses such as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), N can also undergo LLPS by itself to form liquid
compartments containing components of SARS-CoV-2’s replication machinery in the
absence of P (Savastano et al., 2020). The concentration of replication machineries in
confined compartments is advantageous for the virus as it accelerates the rate of
replication and transcription as well as nucleocapsid assembly in the case of MeV
(Guseva et al., 2020). Similarly, the influenza A virus (IAV) form liquid condensates that
serve as dedicated genome assembly sites, and the concentration of viral
ribonucleoprotein segments in such inclusions likely expedite the rate of viral genome
assembly (Alenquer et al., 2019). A recent study conducted by Monette et al. (2020)
demonstrated that retroviral nucleocapsid proteins are able to undergo zinc-dependent
LLPS, and the resulting condensates are involved in viral RNA localization and
trafficking as well as viral particle assembly and release. Although the formation of IBs
in infected host cells to facilitate viral transcription and replication appears to be
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ubiquitous feature amongst the majority of viruses, only IBs of selected RNA viruses
were shown to form via LLPS. Since many small and large nucleocytoplasmic DNA
viruses form cytoplasmic or nuclear IBs in their hosts for replication and assembly, it
would be interesting to see if LLPS also drives the formation of these structures
(Netherton et al., 2007). A recent study conducted by Peng et al. (2020) identified two
proteins in the Epstein-Barr virus (EBV) that are able to undergo LLPS, providing the
possibility that other DNA viral proteins may also phase separate to form functional
compartments that aid in mediating infections. Examination of proteins known to
associate or localize within these viral factories for intrinsically disordered regions may
provide some indications as to whether LLPS is involved in the formation of IBs in cells
infected by DNA viruses.
Like other membraneless organelles, viral IBs formed via LLPS should also be
sensitive to factors such as RNA, temperature, ionic strength, and PTMs. However, the
effects of these factors on the integrity of viral IBs and the overall infection have only
been characterized in a few studies. Perdikari et al. (2020) recently demonstrated that
RNA and lower salt concentrations promote phase separation of the SARS-CoV-2 N,
which is consistent with other phase-separated structures. Interestingly, a recent study
conducted by Iserman et al. (2020) indicated the phase separation of SARS-CoV-2 N is
enhanced at febrile temperatures, which is in contrast with most biological polymers that
form via LLPS. Since liquid condensates are extremely sensitive to temperature
fluctuations, it is tempting to speculate that the increase of body temperature in response
to a viral infection may act to induce the disassociation of viral replication compartments.
However, in the case of SARS-CoV-2 the increase in temperature promotes the assembly
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of the N into liquid condensates rather than inhibit it. As no additional studies to our
knowledge has reported the effects of temperature on phase separation of viral proteins, it
would be interesting to see if increasing temperature similarly enhances condensation of
other viral proteins and overall promotes viral propagation. Currently, phosphorylation is
the only PTM that has been characterized in viral protein LLPS. A study conducted by
Zhou et al. (2019) indicated the phosphorylation of MeV P modulates the size and
assembly of viral IBs. Curiously, phosphorylation of RABV P has no effects on IBs
despite the fact that both MeV and RABV are members of the Mononegavirales order
(Nikolic et al., 2017). Carlson et al. (2020) further demonstrated the phosphorylation of
SARS-CoV-2’s N promotes the phase transition of N oligomers from a filamentous gellike state to a liquid-like state by reducing a subset of multivalent protein-protein and
protein-RNA interactions. Both the gel-like and liquid-like states of N condensates serve
different functions in the viral life cycle, with the liquid-like state involved in viral
replication and transcription. While the role of phosphorylation in viral protein LLPS is
starting to become more apparent, essentially nothing is known about the effects of other
PTMs have on the formation of viral IBs. Since some assembly-prone viral proteins such
as N have reported to be subjected to acetylation and ubiquitination modifications, it
would be interesting to see if these PTMs can affect the formation and integrity of viral
IBs (Giese et al., 2017; Lin et al., 2017; Hatakeyama et al., 2018).
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Figure 2.1. Liquid-liquid phase separation in pathogen infection and survival.
A. Viruses form inclusion bodies to facilitate and accelerate replication, transcription, and
assembly of new virions.
B. Membraneless compartments formed by viruses sequester components involved in the
antiviral response to evade detection and elimination.
C. Intracellular parasites form ribonucleoprotein (RNP) granules in response to changes
in the environment to aid in their survival and propagation. Toxoplasma gondii, for
example, forms RNP granules when in contact with host cell cytosol prior to egress. The
formation of RNP granules were shown to be important for parasite viability.
D. Under growth-inhibiting conditions such as nutrient deprivation, bacteria and fungi
can enter dormancy through modulating the fluidity of their cytoplasm from a liquid-like
state to a solid-like state.
E. Pathogens manipulate the formation of host stress granules in favour of their survival
and replication. Host stress granule formation can be disrupted through a number of
mechanisms, including: cleavage of stress granule proteins, binding of pathogen protein
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to stress granule proteins to prevent their assembly, or partitioning of pathogen protein
into existing stress granules to promote their disassembly.

Table 2.1. Biomolecular condensates formed by viruses and their role in infection.
Infectious Agent
Rabies virus
Vesicular
stomatitis
virus
Measles virus

Human
Metapneumovirus

Proteins Identified in
Biomolecular
Condensate
Nucleoprotein (N)
Phosphoprotein (P)
Nucleoprotein (N)
Phosphoprotein (P)
Multifunctional large
protein (L)
Nucleoprotein (N)
Phosphoprotein (P)

Viral transcription and
replication sites
Viral transcription and
replication sites

Nikolic et al.,
2017
Heinrich et al.,
2018

Viral transcription and
replication sites

Nucleoprotein (N)
Phosphoprotein (P)

Viral transcription and
replication sites

Genome assembly
sites

Zhou et al.,
2019; Guseva et
al., 2020
CifuentesMuñoz et al.,
2017;
Thompson et
al., 2019
Alenquer et al.,
2019

Involve in virus
assembly

Monette et al.,
2020

Viral transcription and
replication

Savastano et al.,
2020

Attenuation of
antiviral response via
sequestration of p65,
p38-P, OGT
Regulate host gene
expression

Jobe et al.,
2020;
Fricke et al.,
2013
Peng et al.,
2020

Influenza A virus

Nucleoprotein (N)
RdRp subunits (PB1,
PB1, PA)
Rab11
Human
Nucleocapsid protein
immunodeficiency (NC)
virus type 1
Severe acute
Nucleoprotein (N)
respiratory
syndrome
coronavirus 2
Respiratory
Nucleoprotein (N)
syncytial virus
Phosphoprotein (P)

Epstein Barr virus

EBNA2
EBNALP

Role in Infection

References

22

2.5.1.2. Antagonizing Antiviral Responses with Viral Inclusion Bodies
Membraneless compartments formed by viruses upon infection are not only
involved in viral transcription and replication, they are also extensively utilized by
viruses to antagonize the host immune response. For example, the respiratory syncytial
virus (RSV) prevents the activation of host innate immune pathway by sequestering the
nuclear factor-κB (NF-κB) subunit p65 into viral IBs (Figure 2.1B) (Jobe et al., 2020). In
addition to p65, proteins involved in the stress response such as phosphorylated p38
mitogen-activated protein kinase (p38-P) and O-linked N-acetylglucosamine transferase
(OGT) have also been shown to be sequestered into RSV cytoplasmic IBs, which in turn
resulted in the inhibition of stress granule formation in addition to reduced production of
proinflammatory and antiviral proteins (Fricke et al., 2013). Similarly, the ebolavirus
(EBOV) also inhibits stress granule assembly by sequestering stress granule proteins into
viral IBs as well as other cellular proteins to facilitate its replication (Nelson et al., 2016;
Brandt et al., 2020). However, it is unclear whether these host cell proteins are actively
recruited or passively transported into these viral compartments. Previous studies have
observed that viral IB proteins of RSV and severe fever with thrombocytopenia syndrome
virus (SFTSV) interact with components of the innate immune signaling pathway like
tank-binding kinase 1 (TBK1) and melanoma differentiation-associated protein 5 (MDA5)
(Lifland et al., 2012; Wu et al., 2014). It is quite possible that the sequestration of
proteins involved in antiviral defense is facilitated by the binding of assembly-prone viral
proteins to host immune response factors and transporting them to IBs that are primarily
composed by the same viral proteins. If host cell proteins are indeed actively recruited
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into IBs via the aforementioned mechanism, then targeting these viral proteins may be a
viable therapeutic strategy to prevent deactivation of antiviral response by viruses.
The formation of viral liquid compartments has also been shown to induce global
changes in host cell gene expression and physiology in favour of their survival and
replication. In the case of EBV, LLPS of its proteins induced alterations in host gene
expression that may contribute to cancer development. EBV proteins EBNA2 and
EBNALP activate transcription of oncogenes such as Myc and RUNX3 by forming
phase-separated structures at their super-enhancer sites (Peng et al., 2020). The formation
of viral IBs via LLPS to promote viral replication or inactivate host immune response
appears to be a common phenomenon among certain families of viruses. It would be
interesting to see if viral inclusions of other negative-strand RNA viruses are able to
attenuate host immune response via cellular protein sequestration in addition to serving as
replication and transcription sites.
2.5.1.3. Unicellular Eukaryotic Parasites Form RNP Granules In Response to
Changes in Environment
Parasitic protozoans often have complex life cycles that involves infecting
multiple host organisms at different developmental stages. In order to adapt to a wide
range of host environments and to cope with the stresses that the parasite may encounter
during its transit from one host to another, these parasitic protozoans form membraneless
compartments to aid in their survival and propagation (Figure 2.1C). The presence of
RNP granules have been observed in a number of prominent parasitic protozoans when
exposed to stressors such as nutrient deprivation and heat shock. Table 2.2 provides a
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summary of eukaryotic unicellular parasites that are known to form RNP granules, as
well as the type of stressors that induces the formation of these membraneless organelles
and the proteins identified within the granules. Presence of stress granules is wellcharacterized in the Trypanosomatidae family, which includes the causative agent of
African sleeping sickness Trypanosoma brucei and Chagas disease Trypanosoma cruzi.
Numerous studies have described the formation of stress granules when the parasite is
exposed to elevated temperature or is deprived of nutrients, and are reported to contain a
variety of RNA binding proteins (RBPs) including ones commonly found in mammalian
stress granules such as poly(A) binding protein (PABP) and eukaryotic initiation factors
(eIFs) (Cassola et al., 2007; Kramer et al., 2008; Subota et al., 2011; Mani et al., 2011;
Fernandez-Moya et al., 2012). While the heat shock-induced stress granules in T. brucei
resemble the mammalian stress granules in composition, their formation is independent
of eIF2α phosphorylation on a conserved serine residue. Similarly, the presence of PABP
and eIF-containing granules induced by nutrient starvation is also observed in another
fellow Trypanosomatidae member, Leishmania; however, these granules are distinct from
those observed in T. brucei and T. cruzi as they contain ribosomal proteins (Zinoviev et
al., 2012; Shrivastava et al., 2019). Additionally, proteins involved in mRNA stability
such as acetylation lowers binding affinity (Alba), uridine binding protein (UBP),
DRBD3, and ZC3H30 have also been identified to colocalize in Trypanosoma
ribonucleoprotein granules during starvation (Cassola et al., 2007; Subota et al., 2011;
Mani et al., 2011; Fernandez-Moya et al., 2012; Chakraborty & Clayton, 2018; Chame et
al., 2020). As RBPs like Alba are also involved in trypanosome differentiation processes,
it is possible that formation of these membraneless organelles may have a role in parasite
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development and life cycle regulation in addition to transient transcript protection during
stress (Subota et al., 2011). In Amoebozoans, stress granule formation induced by heat
shock have been reported in the causative agent of amoebic dysentery, Entamoeba
histolytica (Katz et al., 2014; Cázares-Apátiga et al., 2017). Proteins reported to localize
within these granules include methylated long interspersed nucleotide element-binding
protein (MLBP), which is known to protect the proliferative form of the parasite from
heat shock by preventing protein aggregation, as well as Tudor Staphylococcal nuclease
(TSN), whose depletion leads to increased cell death during heat shock. In
Apicomplexans, the formation of RNP granules with characteristics akin to stress
granules prior to host cell egress (Figure 2.1C) was observed in Toxoplasma gondii
(Lirussi & Matrajt, 2011; Cherry & Ananvoranich, 2014; Roscoe et al., 2021) However,
unlike stress granules found in Trypanosomatids, RNP granules in T. gondii was not
induced by stressors such as nutrient starvation, suggesting that RNP granule formation is
caused by sudden increase in non-translating RNA rather than gradual translational
repression (Roscoe et al., 2021). Formation of stress granules during the T. gondii lytic
cycle has been shown to be important for infectivity and survival in the extracellular
milieu, as granule-forming parasites have elevated ability to penetrate host cells and are
less likely to undergo apoptosis (Lirussi & Matrajt, 2011). Additionally, a positive
correlation between the number of stress granules and infectivity of the parasite has been
reported, thus further solidifying the importance of stress granule formation in T. gondii
fitness and invasion (Roscoe et al., 2021). In the case of another Apicomplexan phylum
member, Plasmodium berghei, RNP granules are formed as a result of eIF2α
phosphorylation by IK2 which occurs when the parasite is in the salivary gland
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sporozoite stage of its life cycle where it remains quiescent until transmission into a
vertebrae host (Zhang et al., 2010). Similar to RNP granules found in T. gondii, P.
berghei RNP granules contain proteins exclusively found in stress granules like PABP
and eIF2α, but were not induced by stressors that stimulate formation of Trypanosoma
stress granules. Plasmodium RNP granules are likely involved in regulation of parasite
stage conversion, although evidence demonstrating a direct connection is still lacking.
Nevertheless, it is evident that RNP granules play an important role in parasite survival as
well as infectivity, and disruption of RNP granule formation may be a viable strategy to
treat parasitic infections.
Table 2.2. RNP granules in unicellular eukaryotic parasites and their protein components.
RNP granules
observed in
Trypanosoma
brucei

Induced By
Heat shock,
oxidative stress,
carbon source
starvation

Trypanosoma
cruzi

Carbon source
starvation

Leishmania
amazonensis

Carbon source
starvation

Entamoeba
histolytica

Heat shock,
oxidative stress

Proteins known to localize
in RNP granules
TbPABP1-2
TbeIF2A
TbeIF3B
TbeIF4E1-4
TbALBA1-4
TbDRBD3
TbZC3H30

TcPABP1-2
TceIF4E
TcDhh1
TcUBP1-2
TcRBP3,4,5a,6b
TcAlba30
TcSgn1
LeishIF4E-3
LeishPABP2
LeishRPS6
EhMLBP
EhTSN
EhHSP70

References
Kramer et al.,
2008; Subota et
al., 2011; Mani
et al., 2011;
FernandezMoya et al.,
2012;
Chakraborty &
Clayton, 2018
Cassola et al.,
2007;
Chame et al.,
2020; Oliveira
et al., 2021

Zinoviev et al.,
2012;
Shrivastava et
al., 2019
Katz et al.,
2014; CázaresApátiga et al.,
2017
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Toxoplasma
gondii

Exposure to host
cell cytosol
(high [K+])
Oxidative stress

TgHoDI
TgPABPC

Plasmodium
berghei

In salivary gland
sporozoite stage

PbPABP
PbeIF2α

Lirussi &
Matrajt, 2011;
Cherry &
Ananvoranich,
2014;
Roscoe et al.,
2021
Zhang et al.,
2010

2.5.1.4. Bacteria and Fungi Modulate Cytoplasm Fluidity to Enter Dormancy
In response to host-imposed stress such as hypoxia and iron deprivation as well as
antibiotic exposure, pathogenic bacteria may suspend their growth and enter a state of
dormancy in order to survive and persist within their hosts (Rittershaus et al., 2013). An
interesting study conducted by Parry et al. (2014) revealed that the bacteria cytoplasm
assumes a glassy solid-like state with limited intracellular dynamics under energydepleted conditions and phase transitions into a liquid-like state when the cell is
metabolically active, suggesting that the reversible solidification of the cytoplasm is
important for bacteria to assume a dormant state in order to survive growth-inhibiting
conditions (Figure 2.1D). A similar phenomenon was discovered in fungi, where the
decrease in cytosolic pH as a result of starvation induced phase transition of the yeast
cytoplasm from a liquid-like state to a solid-like state (Munder et al., 2016). It was
previously shown that acidification of the yeast cytoplasm drives the assembly of cellular
proteins into higher-order structures, which led researchers to speculate that the formation
of these protein assemblies may promote the liquid-to-solid phase transition of the
cytoplasm (Petrovska et al., 2014). The clustering of cellular proteins in energy-depleted
cells was also observed in bacteria but in the form of aggresomes, which are distinct from
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toxic aggregates of misfolded proteins and inclusion bodies formed from protein
overexpression (Pu et al., 2019). Closer examination of aggresomes revealed that protein
aggregation accumulation is positively correlated to dormant cell ratio and the inhibition
of aggresome formation prevents cells from entering a dormant state, indicating that
aggresomes play a role in regulating and facilitating entry into dormancy. In congruence
with the observations in the yeast study by Munder et al., the formation of these protein
aggresomes in bacteria were shown to be associated with decrease in cytosolic pH but is
unlikely the sole determinant of aggresome formation. While mechanistic details
underlying the solidification of bacterial/fungal cytoplasm and aggresomes formation
remain to be elucidated, it is evident that such reversible phase transition is critical for
bacteria to endure stressful conditions and persist within their hosts.
2.5.2. Manipulation and Interference of Host LLPS Structures by Pathogens
As mentioned previously, the eukaryotic cell employs LLPS for a variety of
processes within the cell, ranging from stress response to DNA repair. Not surprisingly,
liquid condensates also have a key role in innate immune defense against invading
pathogens. The most well-studied example is stress granules, which are membraneless
organelles formed in response to stress signals. Pathogen infections can cause global
translational arrest in the host cell, which induces the formation of stress granules. Stress
granule formation antagonizes pathogen proliferation by depleting host cell translation
machinery that many infectious agents rely on to produce their own proteins as well as
regulate innate immunity signaling cascades. Antiviral stress granules (avSGs), whose
formation are induced upon viral infections, have an important role in antiviral defense
by promoting interferon signaling and production. Specifically, avSGs have been
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reported to act as a critical platform for virus detection by recruiting retinoic acidinducible gene-I-like receptors (RLRs) into viral RNA-containing avSGs, likely to
enhance non-self RNA sensing by the RLRs and trigger antiviral signaling pathways
(Onomoto et al., 2012). Additionally, other antiviral host proteins such as RNase L, PKR,
and 2’-5’ oligoadenylate synthetase (OAS) are also recruited into avSGs, suggesting
inhibition of viral replication may also take place within avSGs. The localization of OAS
and RNase L in avSGs is significant because they amplify interferon signaling by
producing of small RNA cleavage products from cellular or self RNA that activate RLRs
the same way viral RNAs do (Malathi et al., 2007; Onomoto et al., 2012). A recent study
conducted by Kang et al. (2018) demonstrated that OASL1 recognizes foreign viral
RNAs and sequesters them into avSGs where many RLRs localize to promote
interactions between RLRs with the viral RNAs. Results from other studies have further
solidified the role of avSGs as viral RNA recognition sites and antiviral signaling hubs
(Yoo et al., 2014; Manivannan et al., 2020). In addition, a study by Rozelle et al. (2014)
suggests avSGs specifically repress viral translation without affecting host mRNA
translation by sequestering viral mRNA into compartments that lack translational
machineries such as ribosomes. AvSG appears to be an important component of host
immune defense that not only senses non-self RNA and serve as a platform for antiviral
signaling, but also directly limit viral replication by impeding translation of viral mRNA.
As a result, many infectious agents, especially viruses, evolve ways to manipulate stress
granules in favour of their survival and replication in addition to forming their own
biomolecular condensates to facilitate infection. In this section, I explore different ways
in which pathogens exploit stress granules to aid in their survival and propagation.
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2.5.2.1. Pathogen-Facilitated Disruption of Host Stress Granules
A strategy commonly used by pathogens to antagonize host immune response is
to inhibit stress granule formation or disrupt existing stress granules in the host cell.
Table 2.3 provides a summary of pathogens that are known to inhibit stress granules and
their mechanism of action. One main mechanism that viruses utilize to disrupt stress
granules is cleaving proteins that make up stress granules or facilitate their formation
(Figure 2.1E). For example, the encephalomyocarditis virus disrupts host stress granules
through cleaving a key stress granule assembly protein, RasGAP-SH3 domain binding
protein 1 (G3BP1), with viral 3C protease. (Ng et al., 2013). EMCV-induced stress
granules are required for production of interferon β and cytokines, and the disruption of
these stress granules prevents further activation of antiviral proteins which in turn allows
for viral replications to proceed. A similar mechanism is also employed by some
picornaviruses such as poliovirus and foot-and-mouth disease virus as well as feline
calicivirus to disrupt stress granule formation in infected host cells (White et al., 2007;
Visser et al., 2019; Humond et al., 2016). In some cases, inhibition of stress granule
assembly does not involve the cleavage of stress granule proteins but rather involves
binding of viral proteins to stress granule proteins and preventing their ability to nucleate
(Figure 2.1E). For example, Semliki Forest virus, herpes simplex virus, and Japanese
encephalitis virus prevent stress granule assembly by binding to stress granule proteins
G3BP1 or Caprin-1, which reduces their interaction with other stress granule proteins
(Panas et al., 2015; Katoh et al., 2013). Interaction between stress granule protein TIA1,
TIA1-related protein (TIAR) and viral components of West Nile and dengue virus has
also been reported to interfere with stress granule assembly (Emara & Brinton, 2007).
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Correspondingly, SARS-CoV-2 reduces G3BP1 interaction with other stress granule
proteins by phase-separating with G3BP1 and partitioning into stress granules to promote
their disassembly (Figure 2.1E) (Wang et al., 2021; Luo et al., 2020). As mentioned
previously, viruses can sequester host immune factors to attenuate antiviral response.
Similarly, chikungunya virus and Ebola virus can sequester stress granule proteins like
G3BP1 into membraneless organelles to prevent stress granule assembly (Fros et al.,
2012; Nelson et al., 2016; Le Sage et al., 2017). While viruses can directly interfere with
stress granule formation by sequestering stress granule components into viral IBs, they
may also indirectly block stress granule formation by utilizing IBs to conceal viral
components that triggers its assembly. For example, the human parainfluenza virus type 3
(HPIV3) forms IBs composed of N and P to shield viral RNAs to prevent them from
inducing stress granule assembly and being sequestered into stress granules (Hu et al.,
2018). Since stress granules exert their antiviral effects by capturing and confining the
viral RNA in the membraneless compartment to inhibit viral translation, the virus
circumvents this defense response by concealing its RNA with IBs to impede the host
from interfering with its replication. Pathogens can also prevent stress granule formation
by interfering with the PKR/eIF2α pathway. For example, the viral protein ORF75 of
Kaposi’s sarcoma-associated herpesvirus inactivates protein kinase R (PKR) by
inhibiting PKR binding to dsRNA, thus blocking its autophosphorylation as well as
downstream phosphorylation of eIF2α (Sharma et al., 2017). Viral protein-mediated PKR
inactivation is also observed in a variety of viruses, including IAV, Middle East
respiratory syndrome coronavirus, and infectious bronchitis virus (Khaperskyy et al.,
2012; Nakagawa et al., 2018; Gao et al., 2021). In addition to targeting PKR, impairment
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of eIF2α phosphorylation is also a common mechanism utilized by Zika virus,
pseudorabies virus, Junin virus as well as the bacteria Escherichia coli to inhibit stress
granule formation (Amorim et al., 2017; Xu et al., 2020; Linero et al., 2011; Velásquez et
al., 2021). Stress granules antagonize virus proliferation by triggering innate immune
response and reducing the availability of translational machineries in the cytoplasm. As a
result, the disassembly of stress granules due to loss of eIF2α phosphorylation is
advantageous to the virus because they require host translational machineries for
production of viral proteins, and the lack of antiviral response from the host allows the
viruses to continue replicating. Lastly, pathogens like Shigella flexneri act to inhibit stress
granule protein aggregation by interfering or modifying the microtubule network or
transport machinery that is responsible for stress granule assembly (Vonaesch et al.,
2016).
2.5.2.2. Pathogens Induce Host Stress Granule Formation for Replication
While some viruses disrupt stress granules to inactivate host immune response,
there are other viruses that induce formation of stress granules to facilitate viral
replication. Table 2.3 provides a summary of pathogens that are known to induce
formation of stress granules and their mechanism of action. For instance, RSV induces
stress granule formation in infected host cells by activating PKR to facilitate or enhance
its replication, as it was observed that stress granule-forming cells exhibit more robust
RSV protein expression and RSV replication was reduced in G3BP1 knockdown cells
(Lindquist et al., 2010; Lindquist et al., 2011). Hepatitis C virus (HCV) also induces
transient stress granule formation in infected host cells by triggering phosphorylation of
protein kinase R and eIF2α (Figure 2.1E) to reduce interferon-stimulated protein
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synthesis and prevent cellular apoptosis (Garaigorta et al., 2012). In addition, stress
granule proteins TIA-1, TIAR and G3BP1 were found to be necessary for efficient HCV
replication and assembly, suggesting that HCV induces stress granule formation to
facilitate its proliferation. Furthermore, enterovirus 71 induces formation of atypical
stress granules that sequester only cellular mRNA but not viral mRNA to promote and
accelerate viral translation (Yang et al., 2018). While the key to establishing a successful
infection often involves the disruption of host stress granules for many viruses, the
induction of stress granule assembly appears to be critical for efficient replication of
selected viruses.
Table 2.3. Infectious agents and their effects on the fate of host cell stress granules.
Infectious Agent
Poliovirus

Encephalomyocarditis
virus
Foot-and-mouth
disease virus
Feline Calicivirus
Theiler’s murine
encephalomyelitis
virus
Zika virus

Pseudorabies virus

Junin virus

Effect of
Manipulation
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs

Method of Manipulation

References

G3BP1 cleavage by 3C
protease

White et al.,
2007

G3BP1 cleavage by 3C
protease

Ng et al., 2013

G3BP1/2 cleavage by
leader protease

Visser et al.,
2019

G3BP1 cleavage by NS6
protease

Humond et al.,
2016

Exact mechanism
unknown, involves leader
protein
Dephosphorylation of
eIF2α
Co-opt SG proteins for
replication
Inhibit SG formation Dephosphorylation of
or disrupt existing
eIF2α
SGs
Inhibit SG formation Inhibition of eIF2α
or disrupt existing
phosphorylation associated

Borghese &
Michiels; 2011
Amorim et al.,
2017; Hou et al.,
2017; Bonenfant
et al., 2019
Xu et al., 2020

Linero et al.,
2011
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Semliki Forest virus

Herpes simplex virus

Japanese encephalitis
virus
Middle East
respiratory syndrome
coronavirus
Influenza A virus
Kaposi’s sarcomaassociated herpesvirus
Infectious bronchitis
virus

Ebola virus

Human parainfluenza
virus type 3
Chikungunya virus

Severe acute
respiratory syndrome
coronavirus 2
West Nile virus

Dengue virus

Escherichia coli

Shigella flexneri

SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs
Inhibit SG formation
or disrupt existing
SGs

with N and GPC
Binding to G3BP by nsP3

Panas et al.,
2015

Binding to G3BP by ICP8
vhs-mediated destruction
of mRNA in SGs
Binding to Caprin-1 by
JEV core protein

Panas et al.,
2015; Finnen et
al., 2016
Katoh et al.,
2013

Inhibition of PKR
activation by 4a accessory
protein
Inhibition of PKR
activation by NS1

Nakagawa et al.,
2018

Inhibition of PKR
activation by ORF57

Sharma et al.,
2017

Regulation of viral dsRNA
accumulation and
inhibition of PKR
activation by nsp15
Inhibit SG formation Sequestration of SG
or disrupt existing
proteins into inclusion
SGs
bodies
Inhibit SG formation Prevent PKR activation by
or disrupt existing
shielding viral RNA in
SGs
viral inclusion bodies
Inhibit SG formation Sequestration of G3BP1 by
or disrupt existing
nsP3 into cytoplasmic foci
SGs
Inhibit SG formation N partitions into SGs and
or disrupt existing
reduce G3BP1 interaction
SGs
with other SG components
Inhibit SG formation Interaction between TIAor disrupt existing
1/TIAR and WNV viral
SGs
proteins
Inhibit SG formation Interaction between TIAor disrupt existing
1/TIAR and DV viral
SGs
proteins
Inhibit SG formation Potentially through
or disrupt existing
inhibition of eIF2α
SGs
phosphorylation
Inhibit SG formation Hinders movement of SG
or disrupt existing
proteins into SGs

Khaperskyy et
al., 2012

Gao et al., 2021

Nelson et al.,
2016; Le Sage et
al., 2017
Hu et al., 2018

Fros et al., 2012

Wang et al.,
2021; Luo et al.,
2020
Emara &
Brinton, 2007
Emara &
Brinton, 2007
Velásquez et al.,
2021
Vonaesch et al.,
2016
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SGs
Respiratory syncytial
virus

Hepatitis C virus

Enterovirus 71

Inhibits SG protein
aggregation
Induce SG formation Activation of PKR

Induce SG formation Activation of PKR
Co-opt SG proteins for
replication
Induce atypical SG
Cleavage of eIF4GI by 2A
formation
protease

Lindquist et al.,
2010;
Lindquist et al.,
2011
Garaigorta et al.,
2012
Yang et al., 2018

2.6. Concluding Remarks
Within the last decade, numerous studies have demonstrated the involvement of
LLPS in diverse biological processes and disease pathogenesis. Evidence is now
mounting that pathogens exploit LLPS to ensure productive replications within the host
cell milieu and antagonize host defense mechanisms to prevent their elimination. While
remarkable progress has been made in the recent years towards elucidating the role of
LLPS in facilitating pathogen infection and survival in host milieu, we are still far from
fully understanding the important mechanistic details of these processes. As more and
more pathogens gradually develop resistance against drugs that are currently available on
the market, the need for novel therapeutics is greater than ever. Further investigation of
liquid condensates formed by infectious agents and their involvement in various stages of
the pathogen’s life cycle and evasion from host innate immune detection will provide
crucial information that will aid in the development of effective treatments against these
resilient pathogens.
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CHAPTER THREE
Utilization of Model Membranes to Investigate the Influence of
Toxoplasma gondii SUMO Peptide on Protein-Lipid Interaction

This chapter reports and summarizes the research work done on investigating the
influence of Toxoplasma gondii small ubiquitin-like modifier peptide on protein-lipid
interaction using model membrane systems. The first section presents a literature review
on cell membranes, lipid rafts, the formation of the parasitophorous vacuole membrane
(PVM) and its components in Toxoplasma gondii, SUMOylation as a post-translational
modification as well as its role in infectious diseases and influence on cellular processes
in T. gondii. The literature review is followed by the research objectives section which
describes the aim and hypothesis of the project, the materials and methods section that
outlines the materials and techniques used in this study, the results and discussion section
that presents and analyzes the experimental findings, and the conclusion and future
direction section that outlines the next steps to take for the project.

3.1. Literature Review
3.1.1. Overview of the Cell Membrane and Lipid Rafts
All cells are delimited by the plasma membrane that serves as a barrier separating
the interior from the surrounding environment. The cell membrane is a lamellar structure
with a hydrophobic matrix and consists primarily of amphipathic lipids arranged in a
double-layer structure as well as proteins that are distributed across the bilayer. About
50% of the membrane are composed of lipids, with phospholipids being the most
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abundant lipid species in the membrane followed by cholesterol. Proteins make up the
other 50%, of which some are either embedded in the lipid bilayer or associate with the
polar head groups of the lipids in the bilayer (Bernardino de la Serna et al., 2016). In
addition to lipids and proteins, carbohydrates are also found on the surface of the cell
frontier that are conjugated to either proteins or lipids in the membrane. Eukaryotic cell
membranes are asymmetric in the sense that the lipid, protein, and carbohydrate
composition of the two bilayer leaflets are distinct from one another (Rothman & Lenard,
1977). The outer or extracellular leaflet of the membrane tends to be enriched in neutral
and zwitterionic lipids such as phosphatidylcholine (PC) and sphingomyelin (SM), while
the inner or cytoplasmic leaflet is mostly composed of anionic lipids including
phosphatidylserine (PS) and phosphatidylinositol (PI) species. This asymmetry is actively
maintained by translocating enzymes such as flippases, floppases, and scramblases, as
transverse movement of lipids between the two leaflets is thermodynamically
unfavourable unlike lateral diffusion (Devaux et al., 2008; Marquardt et al., 2017). The
asymmetric distribution of membrane components has physiological significance; for
instance, the difference in charge between the two leaflets of the membrane contributes to
generating a membrane potential, which is important for signal transmission in excitable
cells and also for regulating a number of processes such as proliferation, differentiation,
and migration in non-excitable cells (Gurtovenko & Vattulainen, 2007; Abdul Kadir et al.,
2018). Membrane asymmetry generated by PS flipping is also important for inducing
curvature of the membrane necessary to form vesicles or tubules for protein transport (Xu
et al., 2013). Additionally, translocation of PS from the inner leaflet to the outer leaflet in
activated platelets has been shown to be involved in blood coagulation, as the PS-
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containing outer leaflet serves as a platform for concentrating coagulation factors and
thus increasing thrombin formation (Zwaal et al., 1989). In the case of apoptotic cells,
flipping PS to the extracellular side of the membrane act as a signal for the macrophages
to ingest the cell (Clarke et al., 2020). Loss of membrane asymmetry can lead to diseases
such as Scott syndrome, a bleeding disorder caused by deficiency in platelet procoagulant
activity as a result of low scramblase activity, further highlighting the importance of
membrane asymmetry in cell physiology.
Over the course of decades, numerous models describing the organization of
membranes have been proposed as technological advances enable closer analysis of
membrane components. One of the most well-known membrane model is the fluid
mosaic model proposed by Singer and Nicolson in 1972, which describes the cell
membrane to be composed of phospholipids that assumes the form of a fluid bilayer with
globular proteins embedded in the matrix of phospholipids in a random fashion. While
the fluid mosaic model was able to explain most of the existing experimental data at the
time, there are several limitations to this model with one being the failure to account for
lipid-mediated lateral heterogeneity (Bagatolli & Mouritsen, 2013). Observations of lipid
segregation and compositional differences of lipids in the apical and basolateral domain
of the plasma membrane in polarized cells were reported by numerous studies, which
subsequently gave rise to the lipid raft hypothesis proposed by Simons and Ikonen
(Shimshick & McConnell, 1973; Grant et al., 1974; Simons & van Meer, 1988; Simons &
Ikonen, 1997). The lipid raft hypothesis postulates the lateral organization of lipids into
distinct domains or rafts is driven by preferential packing of cholesterol and sphingolipids,
which serve as designated platforms for certain lipid-lipid and protein-lipid interactions
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to occur by selectively recruiting or excluding membrane proteins (Simons & Ikonen,
1997). The idea that cholesterol mediates the organization or phase separation of
membrane lipids into functional ordered domains originates from previous observations
on cholesterol’s effect on lipid bilayer fluidity (Ipsen et al., 1987). At temperatures below
their melting temperature (Tm), pure phospholipid bilayers assume the solid-ordered gel
phase (lβ) and transitions to a liquid-disordered fluid phase (ld) at temperatures above
their Tm, which is also the physiologically relevant phase. However, the physical state of
lipid bilayers can be significantly altered by high levels of cholesterol. Cholesterol
possesses a bulky four fused hydrocarbon ring structure with little conformational
flexibility, which intercalates between the lipid acyl chains and acts to increase their
conformational order in the ld phase by causing the acyl chains to become more closepacked and compacted, or decrease lipid acyl chain order in the lβ phase by disrupting the
tight packing of the acyl chains. The presence of cholesterol rigidizes the liquiddisordered phase but also fluidizes the gel phase, which gives rise to an intermediate
liquid-ordered phase (lo) characterized by increased lipid-packing density as seen in the
gel phase with substantial lateral mobility of proteins and lipids as seen with liquiddisordered phase (Ipsen et al., 1987; Owicki & McConnell, 1980). This intermediate lo
phase observed in model membranes has been used to describe the state of lipid
components in the raft domains present in the cell membrane. In addition to cholesterol,
certain properties of sphingolipids also create a favourable membrane environment for
domain formation. The natural occurrence of hydrophobic chain length asymmetry in
sphingolipids such as sphingomyelin can lead to non-ideal mixing of lipids with different
packing properties, potentially resulting in the formation of domains (Ramstedt & Slotte,
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2002; Rietveld & Simons, 1998). The highly saturated nature of sphingolipids also allows
tighter packing with other lipids and thus promoting the formation of ordered domains.
Lipid rafts have been proposed to facilitate a myriad of key cellular processes such as
signal transduction, lipid and protein trafficking, and cytoskeletal organization (Alonso &
Millán, 2001; Ouweneel et al., 2020; Gomez-Llobregat et al., 2013). Furthermore, lipid
rafts are heavily involved in pathogen infection as viruses, bacteria, and parasites exploit
and manipulate host membrane nanodomains for cellular entry as well as other stages of
their life cycle (Ripa et al., 2021; Chatterjee et al., 2021; Goldston et al., 2012).
Perturbation or alteration of lipid raft components is thought to be implicated in diseases
such as neurological disorders and cancer (Marin et al., 2013; Mesa-Herrera et al., 2019;
Vona et al., 2021). While numerous studies have demonstrated the multifaceted roles of
lipid rafts in cell physiology and diseases, they have only been observed in artificial
membranes and isolated plasma membranes but not in live cells due to their nanoscopic
size and transient nature, which makes direct detection of these nanodomains difficult
with current technologies available (Levental et al., 2020). Nevertheless, there are several
methods and techniques that have been instrumental to expanding our understanding on
lipid rafts and membrane phase separation. The process of characterizing transient and
nanoscopic domains in a system as complex and dynamic as the cell membrane is made
simpler with the use of model bilayers, whose composition can be tailored with high
precision and can be studied at thermodynamic equilibrium (Walde et al., 2010). Giant
unilamellar vesicles (GUVs) are model membranes routinely used to study phase
behaviours of binary or ternary lipid mixtures, which are vesicles consisting of a lipid
bilayer with a diameter of 1–100 μm that are made from well-defined pure lipid mixtures
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and can be generated using a variety of different methods including gentle swelling and
electroformation (Morales-Penningston et al., 2010). GUVs are often used in conjunction
with fluorescent probes to visualize lateral membrane organization, as these fluorescent
probes can identify domain phase states by preferentially partitioning into the lo or ld
phase. While GUVs have been useful for studying phase separation of simple lipid
mixtures, artificial membranes cannot effectively recapitulate the lipid diversity of
biological membranes which are much more complex in composition. Giant plasma
membrane vesicles (GPMVs), on the other hand, are vesicles or blebs derived directly
from live mammalian cells via chemically-induced vesiculation that retain the same lipid
and protein composition as living membranes (Baumgart et al., 2007a). GPMVs isolated
from cultured mammalian cells also exhibit membrane phase separation into distinct fluid
domains as demonstrated by the partitioning behaviour of fluorescent probes with phase
preferences. Fluorescence-based methods such as fluorescence quenching and
fluorescence resonance energy transfer (FRET) are commonly used to detect and
characterize phase-separated lipid domains in model and biological membranes, as these
methods can provide information about the spatial proximity of molecules on a distance
scale as well as their immediate environment (Silvius & Nabi, 2006). In addition to
microscopy-based methods, detection and characterization of lateral heterogeneities in
membranes have also been achieved using electron spin resonance spectroscopy and
neutron scattering (Levental et al., 2020; Marquardt et al., 2015).
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3.1.2. Toxoplasma gondii Invasion Mechanism and Formation of the
Parasitophorous Vacuole Membrane
One key function of the plasma membrane is to provide protection for the cell,
which includes keeping certain unwanted substances such as infectious agents from
gaining entry into the cell. The plasma membrane acts as a major barrier that prevents
pathogens from hijacking the cell’s machinery to propagate. As a result, infectious agents
such as the successful parasite Toxoplasma gondii have evolved a unique yet extremely
effective mechanism that allow them to overcome this physical barrier, which they must
traverse in order to successfully establish an infection. Toxoplasma gondii is an
obligatory intracellular organism belonging to the Apicomplexa phylum, which includes
prominent mammalian pathogens such as Plasmodium and Cryptosporidium (Kim &
Weiss, 2010). The parasitic protozoan was first discovered in a rodent Ctenodactylus
gundi by Nicolle and Manceaux and in a rabbit by Splendore back in 1908 (Dubey, 2008).
It was initially mistaken as the trypanosome Leishimania but was later renamed to
Toxoplasma gondii by Nicolle and Manceaux based on its morphology, with “toxo”
meaning arc or bow and “plasma” meaning life. T. gondii is considered one of the most
successful parasites in the world, as it is able to infect virtually any nucleated cells and
thus possesses an incredibly broad host range that includes humans, birds, and marine
mammals. The parasitic protozoan was also detected in five different species of snakes,
indicating that T. gondii infection is not exclusive to warm-blooded animals (Nasiri et al.,
2016). T. gondii is responsible for causing Toxoplasmosis, a disease that affects half of
the total population in the world and a leading cause of death in HIV/AIDS patients
(Flegr et al., 2014; Basavaraju, 2016). Like many other parasitic protozoans, T. gondii
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has a complex life cycle that involves many different developmental stages. Specifically,
T. gondii can interconvert between an actively-replicating form called tachyzoites and a
slowly-replicating dormant form called bradyzoites in response to host immune attacks
and exogenous stress in the asexual stage of its life cycle (Skariah et al., 2010). T. gondii,
as well as other members of the Apicomplexa phylum, utilizes an interesting mechanism
to cross the plasma membrane barrier to gain entry into the cell, which requires
significant energy expenditure from the parasite rather than the host to facilitate its
uptake. The invasion process is initiated when the parasite encounters and attaches to the
cell surface of a potential host through adhesin molecules, followed by secretion of
proteins required for invasion from the parasite’s specialized organelles, namely
micronemes and rhoptries (Shen & Sibley, 2012; Kato, 2018). These proteins form a
complex that anchors the parasite tightly to the host plasma membrane and cytoskeleton,
which is referred to as the moving junction. Once a tight connection between the apical
end of the parasite and the membrane is established, the parasite forcibly penetrate the
cell by invaginating the plasma membrane through gliding motility powered by the
parasite’s own actin-myosin motor system (Sibley et al., 1998). The portion of the host
membrane that is pushed inward by the invading parasite envelops the parasite once it is
inside of the host cytoplasm, forming the parasitophorous vacuole (PV) in which the
parasite resides until egress. While studies have demonstrated that lipid components of
the parasitophorous vacuole membrane (PVM) are almost exclusively derived from the
host plasma membrane rather than contributed by the parasite itself, it is however
deprived of transmembrane proteins yet enriched with GPI-anchored proteins (Suss-Toby
et al., 1996; Mordue et al., 1999; Caffaro & Boothroyd, 2011). The lack of host
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transmembrane protein observed in the PVM was initially thought to be due to the
inability of these proteins to diffuse through the moving junction during parasite invasion
because of their large extracellular domains, and the enrichment of GPI-anchored
proteins is likely a result of preference for lipid rafts in the PVM, as GPI-anchored
proteins are commonly associated with membrane nanodomains (Mordue et al., 1999).
However, it was revealed that the selective exclusion of transmembrane proteins is
independent of their extracellular domains, and lipid raft association is not a prerequisite
for host membrane component inclusion into PVMs as both raft and non-raft lipids were
able to traverse through the moving junction and were incorporated into the PVM
indiscriminately while many transmembrane proteins associated with rafts were still
excluded from the PVM (Charron & Sibley, 2004). While raft association is not required
nor sufficient for membrane components to pass through the moving junction, it does
appear to promote their incorporation into the PVM as many raft lipids such as
cholesterol and GM1 as well as GPI-anchored proteins are included in the PVM. These
findings suggest that selective partitioning of host membrane components into the PVM
is a highly sophisticated process that is determined and influenced by multiple
mechanisms. Although raft lipids and proteins are present in T. gondii PVM, formation of
domains in the PVM has yet to be investigated. However, lateral heterogeneities in the
PVM of another Apicomplexan member Plasmodium have been observed, and a recent
study reported the presence of raft domains in the luminal leaflet of the T. gondii inner
membrane complex (IMC), which are double membrane structures located beneath the
parasite plasma membrane (Goldberg & Zimmerberg, 2020; Konishi et al., 2021).
Nevertheless, it is evident that exclusion of membrane proteins from the PVM is
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important for parasite survival in host milieu, as the absence of these proteins likely
prevents fusion of the PV with lysosomes.
3.1.3. Modifications of the Parasitophorous Vacuole Membrane
The PVM is subjected to significant modifications almost immediately after
invasion is completed to create an environment suitable for parasites to replicate in and
evade host detection and elimination. Since T. gondii is unable to synthesize many of the
nutrients required for its growth and the PVM is essentially devoid of host
transmembrane proteins that functions as nutrient transporters, modification of the PVM
to gain access to these molecules is essential (Coppens, 2013, Clough & Frickel, 2017).
Majority of the PVM modifications are facilitated by parasite proteins secreted from
rhoptries and dense granules either during or after invasion. Rhoptry proteins (ROPs) are
mostly identified to localize at the PVM and many contain kinase domains that are either
active or inactive, while dense granule proteins (GRAs) are found distributed within the
vacuolar space containing membrane tubules as well as the PVM. Studies have
demonstrated that PVM-localized GRA17 and GRA23 mediate passive transport of small
molecules and metabolites (~1300-1900 Da), but not proteins, from the host cytoplasm to
the PV (Schwab et al., 1994, Gold et al., 2015). In order to enhance acquisition of host
nutrients, the PVM has also been modified so that it can project membranous extensions
to the microtubule organizing centre (MTOC) or other organelles, and these PVM
extensions have been reported to contain GRAs or are associated with GRAs (Martin et
al., 2007a). Additionally, the PVM may be modified by parasite proteins to increase
association with specific organelles. For example, numerous studies have indicated that
ROP2 is involved in recruitment of host mitochondria to the PVM for access to lipoic
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acid; however, a separate study by Pernas and Boothroyd demonstrated that ROP2 is not
necessary for mitochondria recruitment which challenges ROP2’s involvement in
mediating mitochondria association with the PVM (Clough & Frickel, 2017; Martin et al.,
2007a). Instead, a novel dense granule protein that localizes at the PVM (subsequently
named as mitochondrial association factor 1 or MAF1) was found to mediate association
between PVM and host mitochondria (Pernas et al., 2014). While the PVM protects the
encased parasites from elimination by resisting fusion with lysosomes, the host cell can
facilitate their destruction through interferon (IFN) γ-induced immune response (Clough
& Frickel, 2017). For example, numerous studies in mice have demonstrated the
accumulation of interferon-inducible GTPases such as immunity-related GTPases (IRGs)
and guanylate-binding proteins (GBP) to the PVM leads to deformation of the membrane
followed by its rupture and ultimately results in death of the parasites within the vacuole
(Martens et al., 2005; Ling et al., 2006; Selleck et al., 2013; Kravets et al., 2016). Due to
the antiparasitic effects of the interferon-inducible GTPases, T. gondii proteins also
decorate the PVM to counter host immune defense mechanisms. For example, ROP5
forms a complex with ROP17 and ROP18 to facilitate the phosphorylation of IRGs at the
PVM, which cause them to disassemble from the vacuolar surface and prevent IFNγinducible GTPase-mediated elimination of T. gondii (Etheridge et al., 2014).
Phosphorylation of IRGs by ROP kinases is further regulated by GRAs, as a study by
Hermanns et al. (2016) showed that GRA7 associates with ROP5 and is essential for
efficient phosphorylation of ROP18’s target, Irga6. Similarly, another dense granule
protein GRA60 was recently found to prevent recruitment of Irgb10 and Irga6 and
associates with ROP18, suggesting that GRA60 may also be used with ROP18 and ROP5
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to inactivate Irga6 (Nyonda et al., 2021). Other studies have also demonstrated that the
recruitment of GBPs to the PVM is countered by ROP16, ROP5, ROP18, and GRA15,
likely through the same mechanism utilized to inactivate IRGs (Virreira Winter et al.,
2011; Selleck et al., 2013).
While it is evident that many processes critical to parasite survival and
proliferation occur at the PVM and further investigation of this organelle is important to
elucidate mechanisms of parasite pathogenicity and host-pathogen interactions, there are
multiple limitations on the study of the PVM. For instance, the PVM is only formed
when the host cell is infected with T. gondii, which limits the amount of material
available for examination (Martin et al., 2007a; Sinai, 2008). Analysis of PVM
components also poses as a challenge since the PVM cannot be purified from host
organelles due to their close associations with the parasite’s own plasma membrane.
However, a recent study by Schnider et al. (2018) utilized the BioID technique to identify
novel proteins at the PVM in Plasmodium, which provides an effective method to study
membrane components.
3.1.4. Post-Translational Modifications of PVM-associated Proteins
The parasite proteins that localize to and modify the PVM are also subjected to a
variety of post-translational modifications (PTMs), which likely affect their association
with the PVM as well as the functions they perform at the PVM. It was discovered that
ROP2 and ROP4 are phosphorylated after their secretion from the rhoptry organelle,
although the effect of phosphorylation on these proteins is unknown (Carey et al., 2004).
However, it is reasonable to speculate that intracellular phosphorylation of ROP2 and

64

ROP4 may be important for PVM functions, as studies have shown that the
phosphorylation of T. gondii proteins plays an important role in the parasite’s lytic cycle
(Joyce et al., 2010; He et al., 2020). In the case of ROP17 and ROP18, which are rhoptry
kinases that are catalytically active, they can self-activate through autophosphorylation
(Qiu et al., 2007; Etheridge et al., 2014). Phosphorylation of ROP17 and ROP18 is
especially important in antagonizing host immune defense as they act to phosphorylate
immunity-related GTPases and prevent destruction of the PVM (Etheridge et al., 2014;
Hermanns et al., 2016). Phosphorylation of dense granule proteins after secretion has
been proposed to regulate their association with membranes in the PV, as a study
conducted by Labruyere et al. (1999) observed that GRA6, initially secreted as a soluble
protein, exhibited increased association with the tubular membrane network in the
vacuolar space when it is phosphorylated. Phosphorylated form of the PVM-associated
dense granule protein GRA7 was found to predominate the fraction enriched with
intravacuolar membrane network and PVM isolated from infected host cells, further
supporting the role of phosphorylation in controlling protein-membrane interactions
within the PV (Neudeck et al., 2002; Dunn et al., 2008). A study conducted by Luo et al.
(2011) revealed that many PVM-associated proteins such as ROP2/4/5/7/18 and GRA3/7
may be subjected to modification by glycosylation, although the effect of glycosylation
on these proteins’ association with and function at the PVM has yet to be elucidated. A
study conducted by Caballero et al. (2016) revealed the presence of palmitoylated
proteins in rhoptry organelles, of which many become associated with the PVM after
their secretion. Specifically, PVM-associated rhoptry proteins ROP2/4/5/7/8/14/18 were
suggested to be palmitoylated. Upon closer examination of the effects of palmitoylation
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on these rhoptry proteins, it was revealed that palmitoylation is important for rhoptry
protein subcellular localization, as rhoptry proteins were dispersed throughout the
cytoplasm in parasites that were treated with palmitoylation inhibitor 2-bromopalmitate
rather than showing a punctuated rhoptry localization as observed in wild-type parasites.
The positioning of the rhoptry organelle was also affected in the absence of
palmitoylation, indicating that palmitoylation of rhoptry proteins plays a role in organelle
localization within the parasite. While palmitoylation appears to be an important PTM for
rhoptry proteins, the effect of rhoptry protein palmitoylation inhibition on the PVM has
yet to be examined. In a global analysis of protein SUMOylation in T. gondii by Braun et
al., it was revealed several PVM-associated rhoptry proteins (ROP4/5/7/8) are potential
targets of SUMOylation. Interestingly, it was discovered in the same study the presence
of SUMO conjugates at the PVM when the parasite is in its dormant form (bradyzoite),
which led to speculations of rhoptry proteins as the SUMO conjugates that were observed
at the PVM. However, it remains to be determined whether rhoptry protein SUMOylation
plays a role in their association with the PVM or their functions at the PVM.
3.1.5 SUMO Protein Modification (SUMOylation)
SUMOylation is a post-translational modification (PTM) where a small ubiquitinlike modifier (SUMO) protein is covalently attached to a specific lysine residue of the
target protein in a reversible manner (Bettermann et al., 2012). SUMO is part of the
ubiquitin-like protein (Ubl) family and possesses tertiary structure analogous to ubiquitin,
another post-translational modifier omnipresent in most eukaryotic organisms (Zhao,
2007). SUMOs are relatively small in size (~11 kDa) and possess a flexible N-terminal
domain that does not substantially impair SUMO function if deleted (Johnson, 2004;
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Bylebyl et al., 2003). All SUMOs are first expressed as larger, immature precursors that
are subsequently processed to generate the mature SUMO protein (Dohmen, 2004;
Pichler et al., 2017). SUMOs are highly conserved in eukaryotes and are essential for
viability of most eukaryotic organisms; eukaryotes such as yeast and invertebrates
possess only one SUMO gene, while higher eukaryotes such as mammals and plants
contain multiple isoforms (Johnson, 2004). The addition of SUMO to protein substrates
can lead to protein stabilization, transcription modifications, and alterations in subcellular
localization and function of target proteins (Bettermann et al., 2012; Hay, 2005).
Furthermore, SUMO conjugation and deconjugation also play critical roles in cell cycle
progression, DNA repair, and stress response (Hay, 2005). Although SUMOylation was
traditionally regarded as a nuclear event, it is now widely known that SUMO substrates
are present in other parts of the cell such as the cytoplasm, plasma membrane,
endoplasmic reticulum, and mitochondria (Martin et al., 2007b; Zhao, 2007; GeissFriedlander & Melchior, 2007). The wide array of SUMO-regulated cellular processes
and the deleterious effects that arises from its abrogation highlights the importance of
SUMOylation to cell survival and function. Therefore, there is no surprise that
SUMOylation is implicated in neurodegenerative disorders, oncogenesis, and infectious
diseases (Celen & Sahin, 2020). For instance, many aggregation-prone proteins
responsible for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease
are substrates of SUMOylation, and these proteins gain stability or evade proteasomal
degradation via ubiquitylation through SUMO conjugation (Celen & Sahin, 2020; Zhao,
2007). Deregulation of SUMO machinery components such as overexpression of SUMO
conjugating enzyme is known to occur in lung, brain, and ovarian cancer (Eifler &
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Vertegaal, 2015). SUMO also can stabilize proteins such as transcriptional effectors
involved in cell proliferation signaling pathways in a pro-oncogenic fashion by
preventing their degradation through antagonizing ubiquitylation (Celen & Sahin, 2020).
As a result, the SUMOylation pathway molecules and its substrates may serve as
potential therapeutic targets.
3.1.6. SUMOylation in Infectious Diseases
SUMOylation has been linked to numerous human diseases including infections
caused by pathogenic microorganisms. Many cellular proteins involved in innate
immunity are SUMO substrates, and SUMOylation of these proteins may contribute to
resistance against invading pathogens or increase host susceptibility to infections by
up/downregulating interferon production (Yang et al., 2017; Hannoun et al., 2016). For
example, SUMOylation can negatively regulate type 1 interferon (IFN) synthesis by
repressing transcriptional activity of interferon regulatory factor (IRF) 3 and 7, thus
reducing transcription of IFNs in response to viral infections (Kubota et al, 2008). On the
other hand, SUMOylation of intracellular pattern recognition receptors (PRRs) such as
retinoic acid-inducible gene 1 (RIG-1) and melanoma differentiation-associated protein 5
(MDA5) is associated with enhanced IFN-I production (Hannoun et al., 2016).
SUMOylation of the cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS) and its
adaptor protein STING also prevents their degradation via ubiquitylation, resulting in
IFN-1 synthesis during the early phase of a viral infection (Hu et al., 2016). Near the end
of an infection, cGAS and STING are deSUMOylated by SUMO-specific proteases
which leads to their degradation and in turn terminating the sustained release of IFN-1.
Not only does SUMOylation regulate activation/production of host antimicrobial proteins
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in response to invasion facilitated by microorganisms, the pathogens also rely on
SUMOylation/deSUMOylation of their own proteins for successful infection and
propagation. For instance, SUMOylation of non-structural protein 1 (NS1) in influenza A
virus is essential for viral growth/multiplication and the enhancement of IFN response
neutralization by NS1 (Santos et al., 2013). In addition, the opportunistic fungal pathogen
Candida glabrata relies on SUMOylation of its proteins for intracellular proliferation in
human macrophages (Gujjula et al., 2016). Furthermore, the deSUMOylation enzyme
Ulp2 was shown to be necessary for C. glabrata virulence attributes such as host tissue
adherence and formation of biofilms. Many pathogens also manipulate host
SUMOylation machinery to alter host environment in favour of infection and/or
replication. In particular, pore-forming toxins secreted by Listeria monocytogenes,
Clostridium perfringens, and Streptococcus pneumoniae trigger degradation of host
SUMO-conjugating enzyme Ubc9, which obstructs the SUMOylation of host regulatory
proteins involved in immune response towards bacterial infections (Ribet et al., 2010).
Protein SUMOylation in host cells was shown to be essential in combating against
bacterial invasion and multiplication, so the degradation of Ubc9 triggered by L.
monocytogenes and other bacteria appears to be a survival mechanism that permits the
proliferation of these pathogens by reducing host SUMOylation status. The E6
oncoprotein of high-risk human papillomavirus (HPV) strains also interferes with host
protein SUMOylation by binding to the SUMO ligase PIASy and prevents SUMOylation
of its targets including tumour suppressor protein p53 (Bischof et al., 2006). Inhibition of
PIASy activity reduces activation of p53 tumor suppressor pathway and in turn prevents
cellular senescence. Additionally, protozoan parasite P. berghei promotes its proliferation
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by downregulating the expression of host SUMO molecules and SUMOylation enzymes
up to 30 folds during infection (Maruthi et al., 2017). Host SUMOylation was shown to
be critical in preventing parasite propagation, as overexpression of SUMO-1 inhibits
intracellular growth of P. berghei exoerythrocytic forms (EEFs) and knockdown of
SUMO-conjugating enzyme Ubc9 is beneficial to EEF development. The lack of
SUMOylation machinery components result in destabilization of the transcriptional factor
SMAD4, which in turn leads to downregulation of SMAD4 targets involved in host
immune response like IRF2BP2 and CDKN1A.
3.1.7. SUMOylation in Toxoplasma gondii
SUMOylation is one of the many post-translational modifications identified in the
parasitic protozoan Toxoplasma gondii. Like other lower eukaryotes, only one gene
encodes for the SUMO protein in T. gondii; deletion or overexpression of the SUMOencoding gene was shown to be lethal to the parasite (Braun et al., 2009). Global
proteomic analysis revealed 120 proteins in T. gondii as potential SUMOylation
substrates. The putative SUMO targets identified are involved in diverse cellular
processes such as transcription regulation, protein translation and folding, cellular
signaling, metabolism, and degradation. Similar to numerous other intracellular
pathogens, T. gondii depend on SUMOylation of its own proteins and manipulation of
host SUMOylation machinery for successful invasion and survival in host cell milieu. T.
gondii also alters host SUMOylation to evade host defense response in the same fashion
as P. berghei by suppressing expression of SUMOylation machinery components which
directly contributes to inhibition of SMAD4 SUMOylation (Maruthi et al., 2017). Since
increased host SUMOylation status elicits anti-parasitic effects, these parasitic protozoans
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evade host defense mechanisms by modulating host SUMOylation processes in favour of
their infection and proliferation. Interestingly, SUMOylated proteins were observed at the
plasma membrane of rapidly replicating tachyzoite forms of T. gondii upon contact with
host cell during invasion (Braun et al, 2009). Furthermore, SUMO-conjugates were
detected at the parasitophorous vacuole membrane (PVM) and cyst wall of dormant
bradyzoite forms of T. gondii in response to stress. This phenomenon suggested that T.
gondii protein SUMOylation may be implicated in facilitating host cell invasion and
formation of protective cyst structures.

3.2. Research Objectives
While increasingly more studies have demonstrated the importance of protein
SUMOylation in regulating numerous cellular processes, little is known about its role in
modulating processes important for T. gondii infection and survival. As it has been
previously demonstrated that SUMOylation is able to influence or regulate protein’s
propensity to interact with the membrane, and an accumulation of SUMO conjugates
were observed at the PVM during bradyzoite differentiation, it is plausible to speculate
that the presence of the SUMO tag on its substrates could act to modulate or influence
their interaction with the lipid membrane (Sedighi et al., 2020; Braun et al., 2009). The
research objective of this study is to examine the influence of T. gondii SUMO peptide on
protein-lipid interaction using model membranes as well as investigate whether TgSUMO
exhibits lipid phase preference. Elucidating the interaction between TgSUMO and the

71

membrane may provide information and clues towards the significance of PVMassociated protein SUMOylation in parasite survival under stress.

3.3. Materials and Methods
3.3.1. Synthesis of Giant Unilamellar Vesicles
Giant unilamellar vesicles (GUVs) were prepared by following an
electroswelling procedure derived from Angelova & Dimitrov. Approximately 300 nmol
of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC; Avanti Polar Lipids, Cat. 850375),
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC; Avanti Polar Lipids, Cat. 850355),
and cholesterol in 300 μL of chloroform were used to prepare GUVs. Small fractions of
naphthopyrene (0.1% mol) and N-(Lissamine Rhodamine B sulfonyl) dioleoyl
phosphatidylethanolamine (LR-DOPE; 0.05% mol) fluorescent probes were added to the
lipid mixture. Lipid films were deposited on indium tin oxide (ITO)-coated glass and
electroswelling was performed at 60 °C for 1 hour at 10 Hz and 1 Vpp. GUVs were
harvested in sucrose solution after temperature drops to 25 °C. The ratios of the lipids in
the GUVs are as follows: 35% DOPC, 35% DPPC, and 30% cholesterol.
3.3.2. Synthesis of Recombinant SUMO Protein tagged with Myc-GFP
3.3.2.1. Plasmid Construction
To monitor SUMO localization, a plasmid containing TgSUMO (ToxoDB ID
TGGT1_266460) and Myc-GFP coding sequences was generated by first linearizing the
pET28-MHL plasmid provided by Cheryl Arrowsmith (Addgene plasmid #26096) using
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restriction enzyme BseRI to generate the vector. The Myc-GFP coding sequence was
PCR amplified using the following primers: MycGFP_fwd_BseRI and MycGFP_rev
(Table 3.1) with HFPCR polymerase (University of Sherbrooke), and the resulting
amplicons were purified using Monarch® Gel Extraction Kit (New England Biolabs, Cat.
#T1020) to generate the first insert. All subsequent PCR reactions and amplicon
purifications mentioned in this thesis were carried out using the same PCR enzyme and
gel extraction kit while closely following the manufacturer’s instructions. The TgSUMO
coding sequence was PCR amplified using the following primers: TgSUMO_fwd and
TgSUMO_rev_BseRI (Table 3.1) and gel extracted to generate the second insert. The
purified vector and inserts were ligated using NEBuilder® HiFi DNA Assembly Cloning
Kit (New England Biolabs, Cat. #E5520) and the ligation reaction mixture was
transformed into NEB® 5-alpha competent E. coli cells supplied by the kit. Positive
clones were identified through PCR screening and the plasmid is hereinafter referred to
as pET28-MHL MycGFP TgSUMO (Figure A1).
Table 3.1. List of oligonucleotide primers used for constructing plasmids expressing
recombinant proteins. Lowercase letters represent non-annealing nucleotides for cloning
purposes and uppercase letters represent nucleotides that anneal to the template.
Name
MycGFP_fwd_BseRI
MycGFP_rev
TgSUMO_fwd
TgSUMO_rev_BseRI
pET28_MHL_MycGFP_FW
pET28_MHL_MycGFP_RV
ROP8_KD_FW
ROP8_KD_RV

Sequences (5’ to 3’)
ttgtatttccagggcGAGCAGAAGCTCATCTC
cttgtcgtccgacatTTTGTATAGTTCATCCATGCC
gatgaactatacaaaATGTCGGACGACAAGAAGGACGATG
caagcttcgtcatcatTGCGCCCCCCGTCTGTTG
ATGACGAAGCTTGCGGCCGCACTC
TTTGTATAGTTCATCCATGCCATGTG
gcatggatgaactatacaaaCTAGTCAGGGGCACATTG
tccttcttgtcgtccgacatGTACTCAGGAGTCTCCATG
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3.3.2.2. Recombinant Protein Expression and Purification
GFP-TgSUMO fusion protein was expressed in BL21-codonPlus (DE3)-RIL
competent E. coli cells (Agilent #230245) and induced by adding 0.15 mM of IPTG and
incubated overnight at room temperature on shaking platform. GFP-TgSUMO proteins
were purified using ProBond™ Nickel-Chelating Resin (Invitrogen, Cat. #R80101) and
eluted with buffer containing 250 mM imidazole, 50 mM NaH2PO4 and 0.2 M NaCl. The
eluate was dialyzed twice in buffer containing 50 mM NaH2PO4 and 0.2 M NaCl for 24
hours. All subsequent protein expression and purifications under native condition
mentioned in this thesis were carried out using the same affinity resin and buffers while
closely following the manufacturer’s instructions. An aliquot of the purified protein
sample was used for quantification via Bradford Assay, and protein purification was
confirmed by subjecting a fraction of the sample to SDS-PAGE analysis. The remainder
of the purified protein was stored at -80 °C for subsequent experiments.
3.3.3. Synthesis of Myc-GFP Protein
3.3.3.1. Plasmid Construction
A plasmid consisted of Myc-GFP but excluding TgSUMO was created to serve as
a negative control in the binding assay. The pET28-MHL MycGFP TgSUMO was
amplified using the following primers: pET28_MHL_MycGFP_FW and
pET28_MHL_MycGFP_RV (Table 3.1) to generate amplicons that is nearly identical to
pET28-MHL MycGFP TgSUMO in sequences but without TgSUMO. The PCR product
was purified via gel extraction and rejoined to form a circular plasmid using the KLD
Enzyme Mix (New England Biolabs, Cat. #M0554S). An aliquot of the KLD reaction
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mix was transformed into NEB® 5-alpha competent E. coli cells (New England Biolabs,
Cat. #C2987). Positive clones were identified through PCR screening and the plasmid is
hereinafter referred to as pET28-MHL MycGFP (Figure A2).
3.3.3.2. Recombinant Protein Expression and Purification
Myc-GFP protein was expressed in BL21-codonPlus (DE3)-RIL competent E.
coli cells (Agilent #230245) and induced by adding 0.15 mM of IPTG and incubated
overnight at room temperature on shaking platform. Myc-GFP proteins were purified via
affinity chromatography under native condition and dialyzed twice to remove the
imidazole. An aliquot of the purified protein sample was used for quantification via
Bradford Assay, and protein purification was confirmed by subjecting a fraction of the
sample to SDS-PAGE analysis. The remainder of the purified protein was stored at -80
°C for subsequent experiments.
3.3.4. Evaluating rTgSUMO Interaction with Artificial Model Membranes
15 μL of DOPC/DPPC/Cholesterol GUVs were gently mixed with 4 μL of
purified GFP-TgSUMO or GFP proteins (0.05 mg/mL) in Eppendorf tubes and incubated
at room temperature for 10 minutes. An aliquot of the lipid-protein mixture was
transferred to a microscope slide and imaged using the Leica DMI 6000B inverted
fluorescent microscope and a Lecia DFC 360FX camera with Leica Advanced
Fluorescence Application Software. BSA of equal concentration (0.05 mg/mL) as the
added recombinant protein was added into the remainder lipid-protein mixture and
incubated for an additional 10 minutes. An aliquot of the mixture is transferred onto the
slide and imaged using the same equipment as described above.
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3.3.5. Homology Modeling of TgSUMO and Electrostatic Potential Surface
Mapping
BLASTp was used to first identify another protein with experimentally
determined structures that has high sequence similarity as TgSUMO to use as template
for homology modeling (Altschul et al., 1990). Multiple sequence alignment and
secondary structure predictions of the template and TgSUMO were carried out using
ESPript (https://espript.ibcp.fr) (Robert & Gouet, 2014). The three dimensional protein
structure model of TgSUMO was generated using SWISS-MODEL
(https://swissmodel.expasy.org) (Bordoli et al., 2008). PyMOL (The PyMOL Molecular
Graphics System, Version 2.0 Schrödinger, LLC) was used to visualize the constructed
TgSUMO model, and the APBS Electrostatic Plugin in PyMOL was employed to map
electrostatic potential surfaces in TgSUMO.
3.3.6. Synthesis of Giant Plasma Membrane Vesicles and Evaluating rTgSUMO
Interaction with Isolated Plasma Membranes
Giant plasma membrane vesicles were generated human foreskin fibroblast (HFF)
cells following the protocol by Sezgin et al. (2012). Confluent HFF monolayers were
rinsed with GPMV buffer (10 mM HEPES, 150 mM NaCl, 2 mM CaCl2, pH 7.4) twice,
and 1 mL of GPMV buffer containing vesiculation agents (25 mM PFA, 2 mM DTT)
were added to the HFF monolayer and incubated for 1 hour at 37°C. Plasma membrane
vesicles were harvested by gently resuspending the buffer in the culture dish and
transferred to a microcentrifuge tube where the vesicles were allowed to concentrate at
the bottom of the tube by gravity. 5 μM of Texas Red™ 1,2-Dihexadecanoyl-sn-Glycero-
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3-Phosphoethanolamine (Texas Red-DHPE) were added to the buffer to label to the
plasma membrane vesicles after isolation. Three different concentrations of GFPTgSUMO and GFP (0.05 mg/mL, 0.01 mg/mL, and 0.005 mg/mL) were incubated with
purified GPMVs and imaged the same way as outlined in Section 3.3.4 with GUVs.
3.3.7. Synthesis of Recombinant TgROP8 tagged with Myc-GFP
3.3.7.1. In silico Identification of SUMOylation Sites in TgROP8
To identify potential SUMOylation sites in TgROP8, four different SUMOylation
prediction programs with different algorithms were utilized. The amino acid sequences of
TgROP8 (ToxoDB ID TGGT1_215775) was obtained from ToxoDB and inputted into
each of the four prediction programs, namely GPS-SUMO (Zhao et al., 2014), SUMOplot
(http://www.abgent.com/sumoplot), SUMOgo (Chang et al., 2018), and JASSA
(Beauclair et al., 2015).
3.3.7.2. Total RNA Isolation and Reverse Transcription
Total RNA was isolated from freshly lysed GT1 strain of T. gondii using TRI
Reagent® (Molecular Research Center, Cat. #TR118) and treated with RQ1 RNase-free
DNase (Promega, Cat. #M6101) to reduce DNA contamination. Treated total RNA was
extracted using 1:1 phenol-chloroform mixture and precipitated using 95% ethanol.
Purified RNA was quantified using NanoDropTM 2000 spectrophotometer (Thermo
Scientific, Cat. #ND-2000). An aliquot of the isolated RNA was subjected to gel
electrophoresis to check for purity and integrity. cDNA synthesis was performed using
500 ng isolated total RNA and MMLV Reverse Transcriptase (New England Biolabs,
#M0253S) following the manufacturer’s instructions.
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3.3.7.3. Plasmid Construction
To monitor TgROP8 localization, a plasmid containing TgROP8 (ToxoDB ID
TGGT1_215775) and GFP coding sequences was created by first amplifying the
predicted kinase-like domain segment of TgROP8 (L266 to Y554) that is rich in
SUMOylation sites from cDNA generated from reverse transcription using the following
primers: ROP8_KD_FW & ROP8_KD_RV (Table 3.1). The amplified ROP8 fragment
was purified via gel extraction and ligated with PCR amplified pET28-MHL MycGFP
outlined in Section 3.3.1 using NEBuilder® HiFi DNA Assembly Cloning Kit (New
England Biolabs, Cat. #E5520). The ligation reaction mixture was transformed into
NEB® 5-alpha competent E. coli cells supplied by the kit. Positive clones were identified
through PCR screening and the plasmid is hereinafter referred to as pET28-MHL
MycGFP ROP8 KD (Figure A3).
3.3.7.4. Recombinant Protein Expression and Purification
Truncated TgROP8 fused to TgSUMO was expressed in BL21-codonPlus (DE3)RIL competent E. coli cells (Agilent #230245) and induced by adding 0.15 mM of IPTG
and incubated overnight at room temperature on shaking platform. Recombinant
TgROP8-SUMO were attempted to be purified via affinity chromatography under hybrid
conditions where the lysate is prepared under denaturing condition but eluted under
native condition following instructions supplied by the manufacturer.
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3.4. Results
3.4.1. Examining the Association between rTgSUMO and Artificial Model
Membrane
The conjugation of the SUMO peptide to its substrates can alter their interactions
with other biomolecules by reducing or adding interaction surfaces. To determine
whether the presence of the SUMO tag could influence the interaction of proteins with
the membrane, the recombinant TgSUMO peptide was tagged with a fluorescent marker,
GFP, and the ability of the tagged protein to associate with model lipid bilayers were
monitored using fluorescence microscopy. Figure 3.1 shows a schematic illustration
summarizing the experimental design that includes the plasmid constructs of the proteins
used in this study. The artificial model membranes, referred to as giant unilamellar
vesicles (GUVs) comprised of DOPC, DPPC, and cholesterol were generated by
electroswelling. GFP-tagged TgSUMO (44 kDa) and GFP (33.6 kDa) proteins containing
two 6x-His tags flanking the protein coding sequence were purified using nickel affinity
chromatography under native condition and analyzed by SDS-PAGE (Figure 3.2).
Quantification of the purified proteins via Bradford assay revealed the concentration of
purified GFP-tagged TgSUMO and GFP to be 1.988 and 0.664 mg/mL, respectively.
GUVs composed of DOPC, DPPC, and cholesterol were generated using electroswelling
technique. 4 μL of 0.05 mg/mL purified proteins were separately incubated with 15 μL of
GUVs to observe for associations between the protein and the lipid, with GFP-GUV
sample serving as the control. From the representative fluorescence images in Figure 3.3,
GUVs incubated with GFP exhibited no discernable green fluorescence at the vesicles,
while GUVs incubated with GFP-tagged TgSUMO exhibited considerable green
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fluorescence at the vesicles compared to the former treatment. This suggests that the
TgSUMO tag itself associates with the lipids in the vesicles to a certain extent.

Figure 3.1. Schematic illustration of plasmids expressing His-tagged GFP-TgSUMO
along with His-tagged GFP (control). GFP and TgSUMO were cloned into a protein
expression vector and purified using nickel-affinity chromatography to examine their
interactions with artificial model membranes. Another plasmid without TgSUMO at
GFP’s C-terminal end was also made to express GFP only. Extent of TgSUMO
association with the lipid membrane will be assessed by comparing the fluorescence
intensities of the GFP-TgSUMO-GUV to the GFP-GUV sample.

Figure 3.2. SDS PAGE image of purified GFP-TgSUMO and GFP. His-tagged GFPTgSUMO and GFP expression were induced by 0.15 mM IPTG and subsequently
purified using nickel affinity chromatography under native condition. Approximately 2
μg of each isolated protein sample were ran on 12% SDS PAGE gel. The band sizes (in
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kDa) of the protein ladder at the first lane are indicated on the left side of the image. The
expected protein size of GFP-TgSUMO and GFP is 44 kDa and 33.6 kDa, respectively.

Figure 3.3. Representative images of GFP and GFP-TgSUMO localization at the GUVs.
4 μL of purified GFP and GFP-TgSUMO with a concentration of 0.05 mg/mL were each
added to 15 μL DOPC/DPPC/cholesterol GUVs labelled with lissamine-rhodamineDOPC membrane marker and incubated at room temperature for 10 minutes prior to
imaging. Scale bar represents 20 μm.

To elucidate the nature of the association between TgSUMO and GUVs, BSA
was added into the protein-lipid mixture and observed using fluorescence microscopy
after 10 minute incubation time. In Figure 3.4, the protein-incubated GUVs did not
fluoresce green in both the GUV + GFP-TgSUMO and GUV + GFP mixture, indicating
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that the interaction between TgSUMO and GUVs was non-covalent as BSA was able to
displace the recombinant protein from the vesicles.

Figure 3.4. Representative images of GFP and GFP-TgSUMO localization at the GUVs
after addition of BSA. 4 μL of purified GFP and GFP-TgSUMO with a concentration of
0.05 mg/mL were each added to 15 μL DOPC/DPPC/cholesterol GUVs labelled with
lissamine-rhodamine-DOPC membrane marker and incubated at room temperature for 10
minutes. 4 μL of 0.05 mg/mL BSA were subsequently added to the lipid-protein mixture
and incubated for an additional 10 minutes prior to imaging. Scale bar represents 20 μm.

3.4.2. TgSUMO Lipid Phase Preference
As the previous experiment had demonstrated certain extent of interaction
between TgSUMO and GUVs, it is of interest to examine whether TgSUMO could
potentially alter the phase preference of its substrates. The phase preference of TgSUMO
was first examined by incubating GFP-TgSUMO proteins with GUVs that were made of
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three species of lipids: unsaturated phospholipid (DOPC), saturated phospholipid (DPPC),
and cholesterol. The distinct fluid phases of the ternary lipid mixtures were tracked with
lissamine rhodamine-DOPC (excitation 560 nm, emission 583 nm) and naphthopyrene
(excitation 430 nm, emission 460-500 nm) fluorescent membrane markers, with lissamine
rhodamine-DOPC preferentially partition to the ld phase and naphthopyrene preferentially
partition to the lo phase of the vesicle (Baumgart et al., 2007b). From the fluorescence
images shown in Figure 3.5, red fluorescence was mostly concentrated on the left side of
the vesicle while cyan fluorescence was more concentrated on the right side of the vesicle,
showing coexistence of both fluid phases within the GUV. Green fluorescence from
GFP-TgSUMO was evenly distributed across the vesicle rather than concentrating at
specific parts of the GUVs that exhibited elevated red or cyan fluorescence.

Figure 3.5. Representative images of GFP-TgSUMO and different lipid phases of GUVs.
GFP-TgSUMO was incubated with DOPC/DPPC/cholesterol GUVs for 10 minutes and
subsequently imaged for lipid phase preference. GFP-TgSUMO was visualized using the
green fluorescence filter. The cholesterol-poor ld phase was tracked with lissaminerhodamine-DOPC, which was visualized using the red fluorescence filter. The
cholesterol-rich lo phase was tracked with naphthopyrene, which was visualized using the
cyan fluorescence filter. Scale bar represents 20 μm.
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3.4.3. Analysis of TgSUMO Electrostatic Potential Surfaces
Non-covalent interaction between TgSUMO and the lipids in vesicles may be
attributed to electrostatic interactions between the charged surfaces in TgSUMO and the
head groups of the phospholipids. An analysis of the electrostatic potential surfaces in
TgSUMO was performed to pinpoint regions that may facilitate association with lipids in
the vesicles. As the protein structure of TgSUMO has yet to be solved, the amino acid
sequences of TgSUMO were compared to SUMO of Plasmodium falciparum, whose
structure has been solved using solution NMR (PDB ID: 5GJL; Singh et al., 2017).
TgSUMO shows 75.64% sequence identity with PfSUMO, and multiple sequence
alignment of PfSUMO and TgSUMO using ESPript 3.0 (Robert & Gouet, 2014) revealed
high sequence similarity in the C-terminal region (Figure 3.6A). A protein structure
model for TgSUMO was built using the SWISS-MODEL (Bordoli et al., 2008) with the
solution structure of PfSUMO as the template (Figure 3.6B). Electrostatic potential
surfaces of the TgSUMO model generated from SWISS-MODEL were then mapped
using the APBS Electrostatics Plugin in PyMOL (Figure 3.6C) to determine potential
charged areas in the protein that may facilitate electrostatic interaction with the lipids in
the model membrane. Electrostatic potential surface mapping revealed a region of high
negative electrostatic potential, which is denoted in red in the left-side images of Figure
3.6C. The negatively charged amino acid residues that may contribute to this patch of
negative electrostatic surface include: Asp60, Glu62, Asp72, Glu76, Asp77, and Asp79.
A region of high positive electrostatic potential was also identified in the TgSUMO
model, which is denoted in blue in the right-side images of Figure 3.6C. The positively
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charged amino acid residues that may contribute to this patch of positive electrostatic
surface include: Lys30, Lys32, Lys33, Lys34, Lys36, Lys39, and Arg47.
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Figure 3.6. Protein structure model and electrostatic potential surface map of TgSUMO.
A. Multiple sequence alignment and secondary structure prediction of P. falciparum
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SUMO with T. gondii SUMO using ESPript. α helices and 310-helices (η) are denoted as
squiggles, β-strands are denoted as straight arrows, and strict β-turns are denoted as TT
above the amino acid sequences. Red filled-in boxes with white characters represent
identical amino acid residues, and red characters represent similar amino acid residues.
B. Three dimensional structures of PfSUMO and TgSUMO in ribbon form. A protein
structure model of TgSUMO was generated using SWISS-MODEL, which builds models
using related proteins with already determined structures as templates. The solution
structure of PfSUMO (PDB ID: 5GJL) was selected and used as the template for building
the structure model of TgSUMO.
C. Electrostatic potential surface maps of TgSUMO from two different orientations. The
model created for TgSUMO using SWISS-MODEL was visualized using PyMOL, and
the APBS Electrostatic Plugin was used to generate an electrostatic potential surface map
for the TgSUMO model. The red colour denotes negative charges near the surface, blue
areas denote positive charges near the surface, and white areas denote neutral potential.
The bottom images show the charged amino acid residues that may contribute to the
electrostatic potential surfaces.

3.4.4. Examining the Association between rTgSUMO and Isolated Plasma
Membranes
Association between TgSUMO and membranes was also examined using vesicles
directly derived from live mammalian cells in addition to artificial model membranes, as
they are able to recapitulate the compositional diversity of native, living membranes
better than ternary lipid mixtures. GFP-TgSUMO and GFP were incubated with giant
plasma membrane vesicles in the same fashion as with the GUVs to observe for
membrane association. From the representative fluorescence images in Figure 3.7,
GPMVs incubated with 0.05 mg/mL GFP or GFP-TgSUMO exhibited no green
fluorescence at the vesicles, which is different from what was observed with the GUVs.
The lack of discernable green fluorescence at the vesicles was consistently observed with
all concentrations of the proteins tested in this study, indicating that GFP and GFPTgSUMO did not associate with the isolated plasma membrane.
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Figure 3.7. Representative images of GFP and GFP-TgSUMO localization at the
GPMVs. Equal concentrations of GFP and GFP-TgSUMO (0.05 mg/mL) were each
added to HFF-derived GPMVs. GPMVs were tracked with Texas Red-DHPE membrane
marker and visualized using the red fluorescence filter, and GFP localization were
visualized using the green fluorescence filter. Scale bar represents 20 μm.

3.4.5. In silico Identification of Potential SUMOylation Sites in TgROP8 and
Expression of GFP-TgROP8 KD-TgSUMO
During bradyzoite differentiation, an increase of SUMO conjugates at the surface
of the PVM was detected. It was speculated that rhoptry proteins were the SUMO
conjugates observed at the PVM, as six rhoptry proteins were identified to be
SUMOylation targets via mass spectrometry and four of the identified rhoptry proteins
are known to localize at the PVM after secretion from the rhoptry organelle (Braun et al.,
2009). Since it has been previously demonstrated that SUMOylation is able to alter the
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ability of its membrane-associated substrate to interact with the lipid bilayer, it is
plausible to speculate that SUMOylation of PVM-associated proteins could influence
their interaction with the membrane (Sedighi et al., 2020). To test this hypothesis, a mass
spectrometry-identified SUMO substrate TgROP8 (previously referred to as ROP2;
Braun et al., 2009) that also localizes at the PVM was chosen for this experiment.
Potential SUMOylation sites for TgROP8 were first identified using four independent
SUMO attachment prediction programs, namely SUMOplot, JASSA, SUMOgo, and
GPS-SUMO. Results for SUMOylation site predictions from the four programs are
compiled in Figure 3.8. Three out of four prediction programs indicated K312 as a
possible SUMOylation site; K325 and K344 were also potential SUMOylation sites listed
by SUMOgo and SUMOplot, respectively. Since the full TgROP8 protein conjugated to
GFP may be too large for efficient expression in E. coli, it was decided to clone a
truncated version of TgROP8 that includes the potential SUMOylation sites into an
expression vector. Ultimately, L266 to Y554 region of TgROP8, which is also the
predicted kinase-like domain of this protein, was chosen to be cloned into expression
vector as all of the predicted SUMOylation sites were concentrated in the E301 to K350
region. The truncated form of TgROP8 was cloned into the same expression vector
containing two 6x His-tag for purification purposes, as well as GFP and SUMO flanking
the truncated region (Figure 3.9A). GFP-TgROP8KD-SUMO (76.9 kDa) expression was
successfully induced but was unable to be purified under native condition as the protein
remained in the pellet (Figure 3.9B). Purification under hybrid condition was
subsequently attempted to solubilize the protein with chaotropic agents followed by
refolding of the isolated protein but with no success (Figure 3.9B).
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Figure 3.8. Compilation of predicted SUMOylation sites in TgROP8 from multiple
SUMOylation prediction programs. Amino acid sequences of TgROP8 (ToxoDB ID
TGGT1_215775) was inputted into four different SUMOylation site predictors:
SUMOplot, JASSA, SUMOgo, and GPS-SUMO. SUMOylation consensus motifs
indicated by SUMOplot, JASSA, SUMOgo, and GPS-SUMO are annotated with yellow
highlight, red text, shaded box, and hollow box, respectively. Underlined lysine residues
are potential SUMO-acceptors indicated by the SUMOylation site predictors.
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Figure 3.9. Expression and purification of GFP-TgROP8KD-TgSUMO.
A. Schematic illustration of plasmid expressing TgROP8 kinase-like domain conjugated
to GFP at its N-terminus and TgSUMO at its C-terminus end.
B. Whole cell lysates of E. coli BL21 cells expressing GFP-TgROP8KD-TgSUMO.
Green fluorescence was observed in the pellet of whole cell lysates of E. coli BL21 cells
induced with 0.15 mM IPTG. Purification of the protein under hybrid condition was
unsuccessful as shown in the eluate after nickel affinity chromatography isolation.

3.5. Discussion
In this study, the influence of T. gondii SUMO peptide on protein-lipid interaction
was investigated using artificial model membranes and isolated plasma membranes.
Recombinant DNA encoding GFP and TgSUMO were cloned into an expression vector
and transformed into E. coli BL21 cells for high-level protein expression (Figure 3.1).
The 6x His-tagged recombinant proteins were purified using nickel affinity
chromatography and purification of the proteins was deemed successful as indicated by
the presence of a thick band at the expected sizes on the SDS PAGE gel (Figure 3.2).
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Upon incubating GFP-tagged TgSUMO proteins with artificial model membranes
(GUVs), an association between GFP-TgSUMO and the lipid vesicle was illustrated by
the distinct green fluorescence at the GUV (Figure 3.3). Incubation of GUVs with GFP
without TgSUMO yielded little to no green fluorescence signal at the vesicle, indicating
that the association between GFP-TgSUMO and GUVs were mostly directed by
TgSUMO itself rather than GFP. Addition of BSA was able to disrupt the interaction
between TgSUMO and the lipids, indicating that the interaction between TgSUMO and
the membrane is non-covalent (Figure 3.4). As it was speculated that the association
between TgSUMO and the GUVs was likely due to electrostatic interaction between the
charged surfaces of TgSUMO and the charged head groups of phosphatidylcholines in
the GUVs, electrostatic potential surfaces were mapped on a structural model of
TgSUMO that was built using PfSUMO as the template due to their high sequence
identity (Figure 3.6). A region of negative electrostatic potential that spans from
approximately Asp60 to Asp79 was identified on the surface of TgSUMO (Figure 3.6C,
left), and this negatively charged surface patch may interact with the positively-charged
choline group in phosphatidylcholine. A region of positive electrostatic potential that
spans from approximately Lys30 to Arg47 was also identified (Figure 3.6C, right), and
this positively charged surface patch may interact with the negatively-charged phosphate
group in phosphatidylcholine within the GUVs.
To further validate and provide more insight into the interaction between
TgSUMO and the membrane, the same experiment was repeated with GPMVs derived
from HFFs as they preserve the compositional complexity of native plasma membranes
and thus are better for mimicking the lipid-protein interaction at the PVM than GUVs.
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However, the same phenomenon observed in GUVs was not observed in GPMVs as no
association between TgSUMO and GPMVs was detected in all three protein
concentrations tested (Figure 3.7). The discrepancies between the GUV and GPMV
observations may be attributed to the isolation chemicals used to induce vesiculation of
HFFs for this experiment, which are formaldehyde and dithiothreitol. Formaldehyde and
dithiothreitol are non-specific cross-linkers and reducers, which may generate artifacts
that could affect lipid-protein interactions (Steinkühler et al., 2019). This issue can be
circumvented by inducing GPMV formation through osmotic vesiculation rather than
chemical vesiculation (Del Piccolo et al., 2012). Although GPMVs are able to
recapitulate the composition of living membranes, it is important to acknowledge that it is
not a perfect representation of the PVM components as majority of the host proteins are
selectively excluded from the PVM with the exception of GPI-anchored proteins.
Nevertheless, in vitro studies of TgSUMO with GPMVs might still reveal important
information about how it may interact with the PVM.
Upon examination of TgSUMO association with GUVs exhibiting phase
coexistence, it was revealed that TgSUMO itself exhibited no phase preference as
indicated by the even distribution of green fluorescence across the GUV (Figure 3.5).
From the results obtained, it is unlikely that TgSUMO itself would be responsible for
directing its substrates to partition into raft domains unlike lipid post-translational
modifications such as palmitoylation that are capable of modulating raft localization of its
substrates and clustering of proteins in the membrane (Zhang et al., 1998). However, it is
unknown whether TgSUMO could indirectly influence or alter the lipid bilayer phase
preference of its substrates, which remains to be further investigated.
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Since it was found that TgSUMO itself exhibited certain extent of association
with membrane lipids, it was hypothesized that TgSUMO may contribute to increasing
the association of its substrates with the membrane. To test this hypothesis, TgROP8, a
PVM-associated protein that was identified to be a SUMOylation substrate in T. gondii
via mass spectrometry, was chosen for this study (Braun et al., 2009). TgROP8 belongs
to the ROP2 superfamily of membrane-associated proteins with a transmembrane domain
at its N-terminus that facilitates its association with PVM (Reese & Boothroyd, 2009;
Foroutan et al., 2018). To express recombinant TgROP8 with and without the SUMO tag
for studying its interaction with artificial model membranes or isolated plasma
membranes, the potential SUMOylation sites were first identified using four different
SUMOylation site predictor software (Figure 3.8). As three out of four programs used
uniformly identified K312 as a potential SUMOylation site, it is highly likely that K312
is a bona fide SUMOylation site in TgROP8. The sequence encoding the predicted
kinase-like domain of TgROP8 (L266 to Y554) was chosen to be cloned for protein
expression, as all of the identified SUMOylation sites fell within this region. Although
TgROP8 possesses a kinase-like domain, it was revealed that TgROP8, like TgROP2, are
catalytically inactive as they lack conservation of key residues in the catalytic triad as
well as the ability to bind ATP due to the protrusion of R228’s side chain into the ATPbinding pocket (Qiu et al., 2009). Initially, it was of interest to couple TgSUMO to K312
in TgROP8 by using a homo-bifunctional maleimide crosslinker as demonstrated in a
study by Wolmarans et al. (2018) to recapitulate the conjugation of TgSUMO to TgROP8
in vivo. The site-specific chemical SUMOylation described involves the introduction of a
cysteine residue after the diglycine motif in the SUMO tag and replacement of the target
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lysine residue with a cysteine residue in the substrate. However, this would have been
only possible if TgSUMO and TgROP8 lacked native cysteine residues which was not
the case as TgSUMO has one cysteine residue and TgROP8 has three near the vicinity of
K312. As a result, a SUMO-conjugated TgROP8 protein was created by fusing TgSUMO
to the C-terminal end of truncated form of TgROP8 instead (Figure 3.9A). While the
protein was successfully expressed as indicated by the green fluorescence, attempts to
purify and refold the said protein were largely unsuccessful (Figure 3.9B). This is not
surprising as overexpression of membrane proteins such as TgROP8 in heterologous
system like E. coli is known to lead to protein misfolding and aggregation into inclusion
bodies, and refolding these proteins has low success rates (Zoonens & Miroux, 2010).
Other strategies to express membrane proteins should be explored in order to generate
recombinant TgROP8-SUMO for future studies.

3.6. Conclusions and Future Directions
In summary, the results of this study showed that TgSUMO associates with
artificial model membranes through non-covalent interactions and exhibits no preferences
in lipid phases, suggesting that presence of TgSUMO may potentially contribute to
increasing its substrate’s association with the membrane but likely does not affect their
partitioning behaviour into raft (lo) or non-raft (ld) phases. The same phenomenon was not
observed in isolated plasma membranes, which may be attributed to presence of
vesiculation chemicals that are known to affect lipid-protein interactions. To further
investigate the influence of TgSUMO conjugation to its PVM-associated substrate
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TgROP8 on their interaction with the PVM, potential SUMOylation sites were identified
and found to be concentrated in the E301 to K350 region, which is also part of the kinaselike domain in TgROP8. Expression and purification of truncated TgROP8 tagged with
TgSUMO and GFP was attempted with no success.
Future directions with this project would be to continue to examine the effect of
TgSUMO conjugation on the interaction of its PVM-associated substrate, TgROP8, with
the membrane. Other expression and purification strategies should be explored to obtain
functional TgSUMO-tagged truncated TgROP8 proteins in large quantities for in vitro
studies, such as using bacterial host strains like Lemo21(DE3) whose T7 RNA
polymerase activity can be controlled to prevent aggregation of synthesized proteins as a
result of overexpression and minimize toxicity to the cell (Zoonens & Miroux, 2009).
Alternatively, SUMO-conjugated TgROP8 can also be generated in vitro using purified
ligases. Additionally, association between TgSUMO and GPMVs should be re-examined
with GPMVs generated by osmotic vesiculation or other methods that do not involve
chemicals that may affect lipid-protein interactions. It would also be of interest to
examine lipid bilayer phase preference of TgSUMO with GPMVs to further solidify
current findings.
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CHAPTER FOUR
Establishing an Inducible CRISPR Interference Gene Repression System in
Toxoplasma gondii

This chapter reports and summarizes the research work done on establishing an
inducible CRISPR interference system for efficient gene knockdown in Toxoplasma
gondii. The first section presents a literature review on the CRISPR/Cas9 system,
CRISPR interference, tetracycline inducible expression system, and genetic manipulation
techniques in Toxoplasma gondii. The literature review is followed by the research
objectives section which describes the aim and hypothesis of the project, the materials
and methods section that outlines the materials and techniques used in this study, the
results and discussion section that presents and analyzes the experimental findings, and
the conclusion and future direction section that outlines the next steps to take for the
project.

4.1. Literature Review
4.1.1. CRISPR/Cas System
4.1.1.1. Overview of the CRISPR/Cas System
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) are
stretches of repeating DNA sequences found in genomes of most bacteria and archaea
(Horvath & Barrangou, 2010). A functional CRISPR locus contains a series of direct
repeats separated by highly variable spacer sequences that were found to have originated
from viruses and plasmids (Barrangou et al., 2007; Doudna & Charpentier, 2014).
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Adjacent to these spacers are CRISPR associated (cas) genes encoding for proteins with
domains characteristic of nucleases, helicases, polymerases, and polynucleotide binding
proteins (Horvath & Barrangou, 2010; Doudna & Charpentier, 2014). Due to the
prevalence of CRISPRs in prokaryotes, researchers were interested in studying the
functions of these DNA repeats and several speculations regarding their functions were
made. It was initially proposed that CRISPRs may be involved in processes such as gene
regulation and DNA repair, but examination of spacer sequences and cas genes led to the
hypothesis that the CRISPR/Cas system may be a defense mechanism of the adaptive
immune system against foreign genetic elements (Horvath & Barrangou, 2010;
Barrangou et al., 2007; Doudna & Charpentier, 2014). Multiple experiments involving
bacteria and their viruses have since then provided evidences for CRISPR/Cas mediated
adaptive immunity (Horvath & Barrangou, 2010; Doudna & Charpentier, 2014).
CRISPR/Cas mediated adaptive immunity works by first incorporating the foreign
genetic element into the CRISPR locus as a protospacer, followed by transcription of the
CRISPR repeat-spacer arrays into precursor-CRISPR RNAs (pre-crRNA); the precrRNAs are processed into mature crRNAs that contain repeating sequences flanking a
single spacer (Doudna & Charpentier, 2014; Karvelis et al., 2013). The mature crRNA
then forms a complex with the Cas proteins that is able to recognize the foreign genetic
element by base-pairing with sequences complementary to the crRNA and then instigate
double stranded breaks (Karvelis et al., 2013). So far, three types of CRISPR/Cas systems
(type I, II, and III) have been identified and each type have their own molecular
mechanisms to facilitate sequence recognition and cleavage (Doudna & Charpentier,
2014; Ran et al., 2013).
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4.1.1.2. CRISPR/Cas System As A Tool for Genome Editing
The CRISPR/Cas system garnered substantial attention in the past decade for its
application as a genome engineering tool. Although other sequence-specific genome
editing technologies such as zinc finger nucleases (ZFNs) and transcription activator-like
effector nucleases (TALENs) exist, CRISPR/Cas is far more superior in terms of ease of
manipulation, cost-effectiveness, and efficiency (Doudna & Charpentier, 2014; Cong et
al., 2013). Type II CRISPR/Cas system derived from Streptococcus pyogenes is one of
the best characterized and most commonly used for genome editing in a wide variety of
eukaryotic organisms (Ran et al., 2013; Gilbert et al., 2013). The type II CRISPR/Cas
system consists of the Cas9 protein, a crRNA, and a trans-activating RNA (tracrRNA).
The crRNA hybridizes with tracrRNA to form a duplex structure, which then forms a
complex with the Cas9 endonuclease to facilitate sequence-specific cleavage (Doudna &
Charpentier, 2014). This system was further simplified by the creation of a chimeric
single guide RNA (sgRNA) in place of the crRNA:tracrRNA duplex, which contains a
20-nucleotide sequence at the 5’ end that recognizes the target site and a double stranded
structure at the 3’ end for Cas9 binding (Doudna & Charpentier, 2014; Gilbert et al.,
2013). The target sequence not only has to be complementary to the sgRNA for cleavage
to occur, it must be adjacent to a protospacer adjacent motif (PAM) (Doudna &
Charpentier, 2014). The Cas9 nuclease performs a double stranded break three bases
upstream of the PAM after binding of the sgRNA to the target sequence (Wu et al., 2014).
The PAM sequence found in S. pyogenes is NGG, where N is any nucleotide (Sternberg
et al., 2014). Without the PAM, sequences exactly complementary to the single guide
RNA are disregarded by the sgRNA/Cas9 complex and Cas9 will not facilitate scission if
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the PAM is not present. The double stranded breaks resulted from Cas9 cleavage are then
repaired through non-homologous end joining (NHEJ) or homologous directed repair
(HDR) (Cong et al., 2013; Wu et al., 2014). NHEJ repair is error prone and creates
insertion/deletion (indel) mutations, thus effectively disrupting the target sequence (Wu
et al., 2014; Wang et al., 2015). HDR repair is not as error prone but is also much less
efficient than NHEJ, and it is used to introduce exogenous sequences into the cut site
with the use of a donor DNA template (Wu et al., 2014; Wang et al., 2015; Aird et al.,
2018).
4.1.1.3. CRISPR Interference
The application of CRISPR/Cas system is not only limited to genome engineering,
it can also be used as a genetic perturbation technique that can silence or activate genes at
the transcriptional level (Zhang et al., 2018). A modified version of CRISPR/Cas system,
called CRISPR Interference (CRISPRi), is able to downregulate the expression of a
specific gene of interest reversibly (Gilbert et al., 2013; Zhang et al., 2018). In CRISPRi,
the Cas9 protein loses its endonuclease activity due to point mutations in both the HNH
and RuvC-like domain, rendering it only able to bind to the sgRNA and target DNA
sequences (Doudna & Charpentier, 2014). The HNH domain is responsible for cleaving
the DNA strand complementary to the single guide RNA, while the RuvC-like domain
cleaves the other DNA strand. This deactivated or catalytically dead Cas9 protein (dCas9)
becomes a RNA-guided DNA binding protein that prevents transcription by sterically
blocking RNA polymerase from accessing the promoter or halting the elongation process
(Gilbert et al., 2013). To increase efficiency of dCas9 repression, it is often fused to
transcriptional repressor domains such as the Krüppel associated box (KRAB) domain to
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effectively block transcription of target genes (Doudna & Charpentier, 2014; Zhang et al.,
2018). CRISPR/dCas9 system not only can be used to silence genes on the transcriptional
level, it can also induce changes in epigenetic states by coupling dCas9 with epigenetic
effector domains such as the chromo shadow (CS) domain (Zhang et al., 2018; Lo & Qi,
2017). The customizable single guide RNA and dCas9 fusion protein complex can
repress expression of multiple genes simultaneously and reversibly with high specificity,
making it a valuable tool for gene-function studies (Doudna & Charpentier, 2014).
CRISPRi has several advantages over RNA interference (RNAi), another popular and
powerful sequence-specific gene silencing mechanism commonly used in functional
genomics studies (Doudna & Charpentier, 2014; Unniyampurath et al., 2016). Unlike the
CRISPRi system that is completely prokaryotic in origin, RNAi is present in many
eukaryotes which may interfere with endogenous pathways and generate off-target effects
in eukaryotic hosts (Doudna & Charpentier, 2014). In addition, RNAi demonstrates
variable efficiencies at silencing long non-coding RNAs (lncRNAs), as most lncRNAs
are localized in the nucleus while RNAi primarily functions and exhibits maximum
knockdown efficiency at the cytoplasm (Goyal et al., 2017; Liu et al., 2017). As a result,
CRISPRi appears to be the most ideal tool for investigating various lncRNA functions as
it demonstrates robust repression of lncRNA expression (Liu et al., 2017).
4.1.2. Tetracycline Inducible Expression System
The tetracycline inducible expression system is a method that allows for
controlled induction or repression of gene expression, which is especially important for
studying lethal or growth arrest genes (Blau & Rossi, 2002). Several inducible systems
have been developed and employed to tightly regulate gene expression in eukaryotes;
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however, the inducing agents are either heavy metals which often causes toxicity to the
host cells, or endogenous cellular products such as hormones that could interfere with
host cellular mechanisms and generate non-specific effects that lead to misinterpretation
of results (Wang et al., 1997; Rossi & Blau, 1998). The tetracycline inducible system has
a significant advantage over these other systems as it is entirely prokaryote-based, which
means the regulatory element of this system would not be able to interfere with
endogenous cellular pathways, thus avoiding the pleiotropic effects that may result (Rossi
& Blau, 1998). The tetracycline inducible expression system is based on regulatory
elements of the Tn-10-encoded tetracycline resistance operon, an antibiotic resistance
mechanism found in the gram negative bacterium Escherichia coli (Hinrichs et al., 1994;
Gossen & Bujard, 1992). The tetracycline repressor protein (TetR) is a regulator of the
membrane-associated protein TetA, which is responsible for pumping tetracycline out of
the bacterial cell before the drug can bind to ribosomes and obstruct protein synthesis
(Kisker et al., 1995). TetR negatively regulates the expression of tetracycline-resistance
genes by binding to the operator sequence (TetO) in the promoter region of the operon,
thus preventing transcription of those genes in the absence of tetracycline (Gossen &
Bujard, 1992). However, in the presence of tetracycline, TetR binds to the antibiotics
instead of the operator sequence to allow for transcription of tetracycline-resistance genes
to occur. In the tetracycline inducible system, TetR is fused with a viral transcriptional
activator domain called viral protein 16 (VP16) to form the tetracycline transactivator
(tTA) (Rossi & Blau, 1998). The tetracycline transactivator recognizes and binds to TetO
adjacent to the target gene’s promoter to stimulate transcription of the target gene in the
absence of tetracycline and represses transcription in the presence of tetracycline (Blau &
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Rossi, 2002). An altered form of the tetracycline transactivator called the reverse
tetracycline transactivator (rtTA) operates in the opposite fashion to the tTA, where
transcription of the target gene occurs only in the presence of tetracycline and vice versa.
Both the tTA and rtTA have been employed in multiple eukaryotic organisms such as
Drosophila and demonstrated effective regulation of target genes. The tetracycline
repressor alone can also be used to induce gene transcription in the presence of
tetracycline or its derivatives such as doxycycline and anhydrotetracycline (ATc) by
transfection of a TetR expressing plasmid or establish a TetR-expressing cell line by
introducing the TetR coding sequence into the host cell’s genome (Yao et al., 2008).
4.1.3. Toxoplasma gondii
4.1.3.1. Toxoplasma gondii as a Model Organism
Toxoplasma gondii is an obligatory intracellular organism belonging to the
Apicomplexa phylum, which includes prominent mammalian pathogens such as
Plasmodium and Cryptosporidium (Kim & Weiss, 2004). The parasitic protozoan was
first discovered in a rodent Ctenodactylus gundi by Nicolle and Manceaux and in a rabbit
by Splendore back in 1908 (Dubey, 2008). It was initially mistaken as the trypanosome
Leishimania but was later renamed to Toxoplasma gondii by Nicolle and Manceaux
based on its morphology, with “toxo” meaning arc or bow and “plasma” meaning life. T.
gondii is considered one of the most successful parasites in the world, as it is able to
infect virtually any nucleated cells and thus possesses an incredibly broad host range that
includes humans, birds, and marine mammals. The parasitic protozoan was also detected
in five different species of snakes, indicating that T. gondii infection is not exclusive to
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warm-blooded animals (Nasiri et al., 2016). T. gondii is responsible for causing
Toxoplasmosis, a disease that affects half of the total population in the world and a
leading cause of death in HIV/AIDS patients (Flegr et al., 2014; Basavaraju, 2016). Out
of all Apicomplexans, T. gondii is most readily manipulated genetically and the easiest to
culture in the laboratory; T. gondii demonstrates high transfection efficiencies (>50%)
and is able to express a wide range of epitope tags, reporter constructs, and exogenous
proteins without any problems (Kim & Weiss, 2004; Szabo & Finney, 2017). T. gondii
also has a number of selectable markers developed to select for transfected parasites such
as dihydrofolate reductase (DHFR), chloramphenicol acetyltransferase (cat), and
hypoxanthine xanthine guanine phosphoribosyl transferase (HXGPRT) (Kim & Weiss,
2004). As a result, T. gondii is considered as a model organism for studying
Apicomplexan biology. Although studies have shown that there are biological differences
amongst the Apicomplexan species, the use of T. gondii as an experimental model is still
able to provide appreciable amount of information regarding the parasite of interest.
4.1.3.2. Genetic Manipulation in Toxoplasma gondii
There are several genetic perturbation techniques that can be utilized to study
functions of T. gondii genes. Non-essential genes can be disrupted using homologous
recombination using single or double crossovers since T. gondii has a haploid genome
(Striepen & Soldati, 2007). Essential genes, on the other hand, can be down-regulated
temporarily using the tetracycline transactivator-based inducible expression system with
ATc as the inducer (Striepen & Soldati, 2007; Meissner et al., 2001). RNA-based
technologies such as antisense RNA, double-stranded RNA (dsRNA) interference and
ribozymes also have been developed and used to regulate expression of genes in the
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parasite (Al-Anouti & Ananvoranich, 2002; Al-Anouti et al., 2003; Crater et al., 2017). In
addition, the CRISPR/Cas9 technology has recently been employed in T. gondii to
efficiently disrupt genes of interests for studying gene functions and incorporate epitope
tags into the genome of the parasite (Shen et al., 2014; Sidik et al., 2014).

4.2. Research Objective
The high specificity and efficiency of CRISPRi has led to its widespread usage in
a variety of organisms for loss-of-function studies. While CRISPR/Cas9 has been used
extensively for genome editing in the parasite Toxoplasma gondii, CRISPRi has yet to be
established in the parasite to downregulate genes on the transcriptional level. The
objective of this study is to establish the CRISPR interference system in Toxoplasma
gondii for examination and analysis of genes of interest in the parasitic protozoan. As the
CRISPR/Cas9 system has previously been shown to facilitate efficient gene disruption in
diverse strains of T. gondii, CRISPRi should also be able to effectively repress
transcription of the targeted gene in the parasite (Shen et al., 2014).

4.3. Materials and Methods
4.3.1. Cell cultures
4.3.1.1. Human Foreskin Fibroblasts
Human Foreskin Fibroblasts (HFF) (ATCC, #1041) were grown and maintained
in Dulbecco’s Modified Eagle Media supplemented with L-glutamine (Gibco, #11965116

084), 10% (v/v) Cosmic Calf Serum (Hyclone, #SH30087.03), and 0.5x antibioticantimycotic (Gibco, #15240-062). Cells were cultured in 60 mm culture dishes and
incubated at 37°C in a 5% CO2 incubator. The cell line was propagated by subculturing
confluent HFF cells using 0.25% Trypsin-EDTA (Hyclone, #SH30042.02) into 60 mm
culture dish, six-well culture plate, and 18 x 18 mm microscope cover glass.
4.3.1.2. Toxoplasma gondii
TetR strain of Toxoplasma gondii was grown and maintained in 6-well culture
plates containing confluent HFF in ED1-MPAX media, which consisted Eagle’s Minimal
Essential Medium (MEM) supplemented with L-glutamate (Gibco, #61000061), 1%
dialyzed fetal bovine serum (Hyclone, #SH30079.03), and 0.5x antibiotic-antimycotic
(Gibco, #15240-062) with 25 μg/mL of mycophenolic acid (MPA) (Sigma, #M5255) and
50 μg/mL of xanthine (Sigma, #X0626). TetRGFP strain of T. gondii was grown and
maintained in 6-well culture plates containing confluent HFF in ED1-pyrimethamine (1
μM) media. Infected monolayers were incubated at 37°C in a 5% CO2 incubator.
4.3.2. Creation of Transgenic Toxoplasma gondii Strain Expressing GFP
4.3.2.1. Construction of pTUB8GFP-DHFR Plasmid
The pTUB8GFPHX plasmid (provided by Dr. David S. Roos at the University of
Pennsylvania; Figure A4) containing the TUB8 promoter and GFP coding sequence with
myc-tag was digested by restriction enzymes SacI and XbaI to remove the HXGPRT
cassette and linearize the plasmid for insertion of the DHFR selectable marker. The
desired digested product was gel isolated using the PuroSPIN™ Replacement Silica Spin
Columns (Luna Nanotech, Cat. #NK107-10S), and instructions from the user manual
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supplied by the manufacturer were closely followed. The pYFP.LIC.DHFR plasmid
(provided by Dr. Vern B. Carruthers at the University of Michigan; Figure A5)
containing the DHFR sequence was PCR amplified using Platinum™ Taq DNA
polymerase (Invitrogen™, Cat. #10966026) with the following primers:
CF_pTub_XbaI_DHFR_cassette_FW and CF_pTub_SacI_DHFR_cassette_RV (Table
4.1). Purified PCR product was obtained through gel isolation using the PuroSPIN™
Replacement Silica Spin Columns (Luna Nanotech, Cat. #NK107-10S). All subsequent
PCR product purifications mentioned in this thesis were carried out through gel
extraction using the same nucleic acid purification kit. The purified amplicon from both
PCR reactions were ligated using the NEBuilder® HiFi DNA Assembly Cloning Kit
(New England Biolabs, Cat. #E5520S) and transformed into NEB 5-alpha competent E.
coli cells supplied by the kit. The resultant plasmid was isolated from the cells by
minipreparation procedures; a protocol derived from a procedure described in Sambrook,
Fritsch, and Maniatis (1989) was used for all minipreparation procedures in this thesis.
The isolated plasmid was subjected to restriction digests to confirm successful ligation of
the PCR products and hereinafter referred to as the pTUB8GFP-DHFR plasmid. The
pTUB8GFP-DHFR plasmid was prepared on a larger scale in a bacterial system and
isolated by medium preparation using PureLink® HiPure Plasmid Midiprep Kit
(Invitrogen™, Cat. #K210004) while following closely to instruction manual supplied by
the manufacturer to yield large number of plasmids to be used in the parasites.
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Table 4.1. List of oligonucleotide primers used for construction of the CRISPRi system
in T. gondii. Lowercase letters represent non-annealing nucleotides for cloning purposes
and uppercase letters represent nucleotides that anneal to the template.
Name
CF_pTub_XbaI_DHFR_cassette_FW
CF_pTub_SacI_DHFR_cassette_RV
5GFPMyc
3GFP1940
gRNA_Hind3pTub8_FW
U6_upstream_RV
FW_TetoKRAB
RV_dCas9ChFP
FW_SphI PolA
RV_SacII PolA
FW_NdeIPol3_promoter
RV_SpeITub_promoter
gRNA_NdeIMycGFP_FW
gRNA_NcoITub8AS_FW
Tub1PM_NdeI_FW
Tub1PM_SpeI_RV
CAT_cassette_Nsi_FW
CAT_cassette_Nsi_RV

Sequences (5’ to 3’)
gggatccactagttctagagcttcgccaggctgtaaatc
gaacaaaagctggagctccaggaattcatcctgcaagtg
ATGCAGGAGCAGAAGCTC
GCCATGTGTAATCCCAGC
tgttcaagcttgcctgcattGTTTTAGAGCTAGAAATAGCAAG
AACTTGACATCCCCATTTACC
gttggcattttttcttgaattcCCTAGTAAAGCTGATATCTCCAC
gatcagcgagctctaggaattcGATTGCGGCCGCACCGGTTTAC
attgggcccgacgtcgcatgTCCCCAGCATGCCTGCTATTC
gctgatcatcgaattcccgcCTGTGCCTTCTAGTTGCCAG
aagaaaaaatgccaacatcaCAAGAAAAAATGCCAACGAG
gcgttgggagctctcccataGATGAGACAAAGTGCGCG
gatacccagatcatatgaagGTTTTAGAGCTAGAAATAGCAAG
ggccatggccaggtcctcctGTTTTAGAGCTAGAAATAGCAAG
cgttgggagctctcccatatgGTCCCGCGTTCGTGAAATTC
aaaaatgccaacatcactagtGTGTCGAAAAAGGGAATTC
cccaacgcgttggatgcatCGCGTGTTCTAACCACAAAC
agaatactcaagctatgcatGGCAAGAATTGTGTTAACCG

4.3.2.2. Transformation of T. gondii by Electroporation
Transfection of TetR strain T. gondii with pTUB8GFP-DHFR plasmid was
conducted via electroporation using a BTX ECM 630. Freshly lysed TetR parasites were
harvested and centrifuged for 5 minutes at 5,000 rpm. The pellet was resuspended in 400
μL of electroporation mixture (120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4
(pH 7.6), 6.25 mM HEPES (pH 7.6), 2 mM EDTA (pH 7.6), 5 mM MgCl2, 2 mM ATP,
and 5 mM glutathione). Approximately 50 μg of pTUBGFP-DHFR plasmid were added
to a 4 mm electroporation cuvette containing the parasites resuspended in electroporation
mixture. The parasites were directly transferred to six-well culture plates containing
confluent HFF cells after electroporation and grown in ED1-MPAX media at 37°C in a
5% CO2 incubator for 24 hours. The ED1-MPAX was subsequently replaced with ED1
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media containing 1 μM pyrimethamine to select for parasites containing the pTUB8GFPDHFR plasmid.
4.3.3. Establishment of a Clonal Cell Line of Transgenic T. gondii
4.3.3.1. Dilution Cloning of Transgenic T. gondii Expressing GFP
Cloning by limiting dilution was carried out to generate a clonal line of transgenic
parasites expressing GFP from a polyclonal pool of parasites that were subjected to
electroporation. The parasites were cloned by 2.27-fold serial dilutions in a 96 well plate
containing confluent HFF cells. Each well was examined for green-fluorescing parasites
using the Leica DMI 6000 inverted fluorescence microscope with the Leica Advanced
Fluorescence Application Suite, and one well containing parasites that expressed GFP
was selected and transferred to six-well culture plates to be grown and maintained in
ED1-pyrimethamine selection media.
4.3.3.2. Confirmation of GFP Expression in the Newly Created Transgenic Strain
GFP expression by transgenic line of parasites was confirmed by presence of
green fluorescence in parasite vacuoles using fluorescence microscopy, and a PCR
analysis was performed to verify the exogenous gene was successfully incorporated into
the parasite’s genome. Genomic DNA of TetR strain parasites and TetR-GFP line of
transgenic parasites was first extracted using Quick-gDNA™ Miniprep Kit (Zymo
Research, Cat. #D3024). The isolated genomic DNA from TetR and TetRGFP strain was
used as template to PCR amplify the GFP coding sequence using Platinum™ Taq DNA
polymerase (Invitrogen™, Cat. #10966026) with the following primers: 5GFPMyc and
3GFP1940 (Table 4.1). The PCR products were subjected to gel electrophoresis using
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1% agarose gel (FroggaBio, Cat. A87-500G) in 1x TAE to confirm the incorporation of
the reporter gene into T. gondii’s genome.
4.3.4. Creation and Introduction of CRISPRi System into T. gondii
4.3.4.1. Generating pTUB8-targeting Single Guide RNA Construct
To create a custom single guide RNA containing the spacer sequence targeting
TUB8 promoter driving GFP expression, the primers gRNA_Hind3pTub8_FW and
U6_upstream_RV (Table 4.1) were designed and the spacer sequence was incorporated
into the pU6 universal plasmid using Q5® Site-Directed Mutagenesis Kit (New England
Biolabs, Cat. #E0554). The resultant plasmid was isolated from the cells by
minipreparation procedures and digested with restriction enzymes to confirm
incorporation of the spacer sequence. The constructed plasmid is hereinafter referred to
as pU6-mycGFP-sg1 plasmid (Figure A6).
4.3.4.2. mycGFP-sg1-dCas9 Plasmid Construction
The CRISPRi plasmid designed to downregulate GFP expression was constructed
by first PCR amplifying a portion of the pAAVS1-NDi-CRISPRi (Gen 1) plasmid
provided by Bruce Conklin from The Gladstone Institutes (Addgene plasmid #73497;
Figure A7) using Platinum™ Taq DNA polymerase (Invitrogen™, Cat. #10966026) with
the following primers: FW_TetoKRAB and RV_dCas9ChFP (Table 4.1), which encodes
the sequence for the tetracycline operator (tetO), KRAB repressor, dCas9 protein, and
mCherry marker. The purified amplicons containing the previously mentioned
components were cloned into pGEM®-T Easy Vector using the pGEM®-T Easy Vector
Systems (Promega Corporation, Cat. #A1360; Figure A8) as per the user’s manual and
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transformed into DH5-Alpha cells for expression. The expressed plasmids were isolated
from the cells by minipreparation procedures. The plasmid was subjected to restriction
digests to confirm incorporation of the amplicon into the vector and hereinafter referred
to as pGEM-T-Easy-dCas9 plasmid (Figure A9). The pGEM-T-Easy-dCas9 plasmid was
double digested with restriction enzyme SphI and SacII immediately downstream of the
mCherry marker to linearize the plasmid. A Poly(A) signal from the pU6 Universal
plasmid provided by Sebastian Lourido from Whitehead Institute of Biomedical Research
(Addgene plasmid #52694; Figure A10) was PCR amplified using Platinum™ Taq DNA
polymerase (Invitrogen™, Cat. #10966026) with the following primers: FW_SphI PolA
and RV_SacII PolA (Table 4.1). Purified PCR product was cloned into the linearized
pGEM-T-Easy-dCas9 plasmid using the NEBuilder® HiFi DNA Assembly Cloning Kit
(New England Biolabs, Cat. #E5520S) and transformed into NEB 5-alpha competent E.
coli cells supplied by the kit. The isolated plasmid was subjected to restriction digests to
confirm incorporation of the amplicon into the vector and hereinafter referred to as
pGEM-T-Easy-dCas9-PolyA plasmid (Figure A11). The pGEM-T-Easy-dCas9-PolyA
plasmid was double digested with restriction enzyme NdeI and SpeI upstream of the
tetracycline operator to linearize the plasmid. A portion of the pU6-mycGFP1-sg1
plasmid containing the U6 promoter, custom sgRNA targeting TUB8, and TUB1
promoter was PCR amplified using Platinum™ Taq DNA polymerase (Invitrogen™, Cat.
#10966026) with the following primers: FW_NdeIPol3_promoter and
RV_SpeITub_promoter (Table 4.1). Purified PCR product was cloned into the linearized
pGEM-T-Easy-dCas9-PolyA plasmid using the NEBuilder® HiFi DNA Assembly
Cloning Kit (New England Biolabs, Cat. #E5520S) and transformed into NEB 5-alpha
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competent E. coli cells supplied by the kit. The isolated plasmid was subjected to
restriction digests to confirm incorporation of the amplicon into the vector and hereinafter
referred to as mycGFP-sg1-dCas9 plasmid (Figure A12). The mycGFP1-sg-dCas9
plasmid was prepared on a larger scale in a bacterial system and isolated by medium
preparation using PureLink® HiPure Plasmid Midiprep Kit (Invitrogen™, Cat.
#K210004) while following closely to instruction manual supplied by the manufacturer to
yield large number of plasmids to be used in the parasites.
4.3.4.3. Introduction of mycGFP-sg1-dCas9 Plasmid into T. gondii
Transfection of mycGFP-sg1-dCas9 plasmid into the transgenic strain of parasites
was conducted via electroporation using a BTX ECM 630. Freshly lysed TetRGFP
parasites were harvested and centrifuged for 5 minutes at 5,000 rpm. The pellet was
resuspended in 400 μL of electroporation mixture (120 mM KCl, 0.15 mM CaCl2, 10
mM K2HPO4/KH2PO4 (pH 7.6), 6.25 mM HEPES (pH 7.6), 2 mM EDTA (pH 7.6), 5
mM MgCl2, 2 mM ATP, and 5 mM glutathione). Approximately 50 μg of mycGFP-sg1dCas9 plasmid were added to a 4 mm electroporation cuvette containing the parasites
resuspended in electroporation mixture. The parasites were directly transferred to sixwell culture plates containing confluent HFF cells after electroporation and grown in ED1
media containing 1 μM pyrimethamine at 37°C in a 5% CO2 incubator.
4.3.5. Determining Optimal Time to Induce dCas9-KRAB Transcription
4.3.5.1. Induction of dCas9 Expression with Anhydrotetracycline
To test whether the CRISPRi system introduced into the transgenic line of
parasites was able to reduce GFP expression, 3 μg/mL (6 μL) of ATc was added to ED1123

pyrimethamine media to induce transcription of dCas9 fusion protein at two different
time points: 0 hour upon parasite infection and 16 hours upon parasite infection.
Electroporated parasites were first grown in ED1-pyrimethamine media and collected
when they have lysed their host cells. These parasites were transferred to two culture
plate wells containing confluent HFF cells on 18 x 18 microscope coverslips, and 3.0
μg/mL ATc was added immediately (0 hours) to the first well. In the second well, 3.0
μg/mL ATc was added after 16 hours since the parasites infected the host cells.
Following the addition of ATc, the parasites were incubated with their host cells at 37°C
in a 5% CO2 incubator for 24 hours after addition of inducer. The same set of experiment
outlined above was repeated but with 6 μL of DMSO instead of ATc to serve as controls.
4.3.5.2. Analysis of Fluorescence Intensity and Vacuole Size via Fluorescence
Microscopy
After the incubation period, cells on the coverslips were washed with 1x PBS
three times, fixed with 3% paraformaldehyde for 5 minutes and permeabilized with
0.25% Triton X-100 for 10 minutes. The coverslips were washed in 1x PBS for 4 times
then blocked with 5% equine serum in 1x PBS for 1 hour at room temperature with gentle
agitation, and nuclear-stained with 3.2 μM Hoechst stain (Thermo Fisher Scientific, Cat.
#H1339) for 10 minutes. The stained coverslips were washed with 1x PBS for three times,
mounted on a glass slide using fluoromount mounting medium, and visualized using
Leica DMI 6000 inverted fluorescence microscope with the Leica Advanced
Fluorescence Application Suite. Sizes and fluorescence intensities of vacuoles for each
treatment were quantified using ImageJ2 (Rueden et al., 2017), and a violin plot of
vacuole size distribution was generated using PlotsOfData (Postma & Goedhart, 2019).
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4.3.6. Determining Optimal Concentration of Inducer for dCas9-KRAB
Transcription
Five concentrations of ATc (0.25 μg/mL, 0.5 μg/mL, 1.0 μg/mL, 2.0 μg/mL, and
3.0 μg/mL) were added to electroporated parasites with the mycGFP-sg1-dCas9 plasmid
16 hours post-infection. The parasites with their host cells were incubated for 24 hours at
37°C in a 5% CO2 incubator after addition of inducer. The coverslips were fixed after the
incubation period, nuclear-stained, and mounted on glass slides as described in Section
4.3.5.2 to visualize the parasites using Leica DMI 6000 inverted fluorescence microscope
with the Leica Advanced Fluorescence Application Suite. Sizes and fluorescence
intensities of vacuoles for each treatment were quantified using CellProfiler 4.1.2
(McQuin et al., 2018), and a violin plot of vacuole size distribution was generated using
PlotsOfData (Postma & Goedhart, 2019).
4.3.7. Different Single-Guide RNA Constructs and Their Effects on CRISPRiMediated Gene Repression
4.3.7.1. Generating Alternative Single Guide RNA Constructs
To determine whether different single guide RNAs targeting different strands or
location of the reporter gene exhibit varying knockdown efficiencies, two additional
single guide RNAs were designed. The template for the site directed mutagenesis was
first generated by digesting the pU6 universal plasmid with NotI and NcoI to remove the
Cas9 sequence. The sticky ends resulting from the restriction digest were blunted using
DNA Polymerase I, Klenow Fragment (Takara Bio, Cat. #2140B) and ligated using Anza
T4 ligase (Invitrogen, Cat. #IVGN2104). The resultant plasmid was subjected to
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restriction digests to confirm the removal of Cas9 and is hereinafter referred to as pU6 (-)
Cas9 (Figure A13). To create the first single guide RNA, the primers
gRNA_NdeIMycGFP_FW and U6_upstream_RV (Table 4.1) were employed to
incorporate the spacer sequence targeting the middle of the GFP coding sequence into the
pU6 (-) Cas9 plasmid using Q5® Site-Directed Mutagenesis Kit (New England Biolabs,
Cat. #E0554). The resultant plasmid was isolated from the cells by minipreparation
procedures and digested with restriction enzymes to confirm incorporation of the spacer
sequence. The constructed plasmid is hereinafter referred to as pU6-mycGFP-sg3 (-)
Cas9 plasmid (Figure A15). To create the second single guide RNA, the primers
gRNA_NcoITub8AS_FW and U6_upstream_RV (Table 4.1) was employed to
incorporate the spacer sequence targeting the nontemplate strand of a different region in
the TUB8 promoter into the pU6 (-) Cas9 plasmid using Q5® Site-Directed Mutagenesis
Kit (New England Biolabs, Cat. #E0554). The resultant plasmid was isolated from the
cells by minipreparation procedures and digested with restriction enzymes to confirm
incorporation of the spacer sequence. The constructed plasmid is hereinafter referred to
as pU6-mycGFP-sg2 (-) Cas9 plasmid (Figure A14). The pU6-mycGFP-sg2 (-) Cas9 and
pU6-mycGFP-sg3 (-) Cas9 plasmids were prepared on a larger scale in a bacterial system
and isolated by medium preparation using PureLink® HiPure Plasmid Midiprep Kit
(Invitrogen™, Cat. #K210004) while following closely to instruction manual supplied by
the manufacturer to yield large number of plasmids to be used in the parasites.
4.3.7.2. dCas9 (-) sgRNA CAT Plasmid Construction
A plasmid containing the TUB1 promoter, tetracycline operator, KRAB repressor,
and dCas9 coding sequence is constructed to be used in tandem with the single guide
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RNA constructs from Section 4.3.7.1. A selectable marker is also included in the plasmid
so a line of parasites that stably expresses the inducible dCas9 system can be established
in the future for other studies. The pGEM-T-Easy-dCas9-PolyA plasmid from Section
3.3.4.2 was first linearized with NdeI and SpeI, and the promoter to be incorporated
upstream of tetO was PCR amplified from pU6 universal using HFPCR enzyme
(University of Sherbrooke) with the following primers: Tub1PM_NdeI_FW and
Tub1PM_SpeI_RV (Table 4.1). The PCR product was gel purified and ligated with the
linearized pGEM-T-Easy-dCas9-PolyA plasmid using NEBuilder® HiFi DNA Assembly
Cloning Kit (New England Biolabs, Cat. #E5520S) and transformed into NEB 5-alpha
competent E. coli cells supplied by the kit. The isolated plasmid was subjected to
restriction digests to confirm incorporation of the amplicon into the vector and hereinafter
referred to as pGEM-T-Easy-dCas9-PolyA-pTUB1 plasmid (Figure A16). To
incorporate a selectable marker into the resultant plasmid, pGEM-T-Easy-dCas9-PolyApTUB1 was first linearized using NsiI and dephosphorylated using Calf Intestinal
Alkaline Phosphatase (Promega Corporation, Cat. #M1821) to prevent vector re-closure.
The chloramphenicol acetyltransferase (CAT) cassette was PCR amplified from
pTUBRnNoBulge-CAT using HFPCR enzyme (University of Sherbrooke) with the
following primers: CAT_cassette_Nsi_FW and CAT_cassette_Nsi_RV (Table 4.1). The
amplicon was gel purified and ligated with the linearized pGEM-T-Easy-dCas9-PolyApTUB1 using NEBuilder® HiFi DNA Assembly Cloning Kit (New England Biolabs, Cat.
#E5520S) and transformed into NEB 5-alpha competent E. coli cells supplied by the kit.
The isolated plasmid was subjected to restriction digests to confirm incorporation of the
amplicon into the vector and hereinafter referred to as dCas9 (-) sgRNA CAT plasmid
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(Figure A17). dCas9 (-) sgRNA CAT plasmid was prepared on a larger scale in a
bacterial system and isolated by medium preparation using PureLink® HiPure Plasmid
Midiprep Kit (Invitrogen™, Cat. #K210004) while following closely to instruction
manual supplied by the manufacturer to yield large number of plasmids to be used in the
parasites.
4.3.7.3. Introduction of sgRNA Constructs and dCas9-KRAB into T. gondii
Transfection of pU6-mycGFP-sg2 & dCas9 (-) sgRNA CAT plasmid pair and
pU6-mycGFP-sg3 & dCas9 (-) sgRNA CAT plasmid pair into the transgenic strain of
parasites was conducted via electroporation using a BTX ECM 630. Freshly lysed
TetRGFP parasites were harvested and centrifuged for 5 minutes at 5,000 rpm. The pellet
was resuspended in 400 μL of electroporation mixture (120 mM KCl, 0.15 mM CaCl2, 10
mM K2HPO4/KH2PO4 (pH 7.6), 6.25 mM HEPES (pH 7.6), 2 mM EDTA (pH 7.6), 5
mM MgCl2, 2 mM ATP, and 5 mM glutathione). Approximately 50 μg of the single
guide RNA constructs (pU6-mycGFP-sg2 or pU6-mycGFP-sg3) and 50 μg of dCas9 (-)
sgRNA CAT plasmids were added to a 4 mm electroporation cuvette containing the
parasites resuspended in electroporation mixture. The parasites were directly transferred
to six-well culture plates containing confluent HFF cells after electroporation and grown
in ED1 media containing 1 μM pyrimethamine at 37°C in a 5% CO2 incubator. The same
set of experiment outlined above was repeated but with DMSO instead of ATc to serve as
controls.
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4.3.7.4. Induction of dCas9 Expression with Different Concentrations of
Anhydrotetracycline
Three concentrations of ATc (0.25 μg/mL, 1.0 μg/mL, and 3.0 μg/mL) were
added to electroporated parasites 16 hours post-infection. The parasites with their host
cells were incubated for 24 hours at 37°C in a 5% CO2 incubator after addition of inducer.
The coverslips were fixed after the incubation period, nuclear-stained, and mounted on
glass slides as described in Section 4.3.5.2 to visualize the parasites using Leica DMI
6000 inverted fluorescence microscope with the Leica Advanced Fluorescence
Application Suite. Fluorescence intensities of vacuoles for each treatment were quantified
using CellProfiler 4.1.2 (McQuin et al., 2018).

4.4. Results
4.4.1. Establishment of Transgenic Line of TetR Parasites Expressing GFP
To create a line of TetR parasites expressing the reporter gene for assessing
CRISPRi knockdown effect, a plasmid containing TUB8 promoter upstream of the mycGFP coding sequence and selectable marker DHFR was constructed and transfected into
TetR (Figure 4.1A). Transfected TetR parasites were first grown in ED1-pyrimethamine
media and regularly subcultured in the same selection media. In the first three weeks of
growing the transgenic parasites in selection media, majority of the parasites were
fluorescing green with the exception of few vacuoles as shown in Figure 4.1B (upper
row). Dilution cloning was then employed to isolate for a single parasite that is
expressing GFP and clone it to obtain a stable transgenic line. The selected well
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containing monoclonal parasites were transferred to six-well plates to be regularly
subcultured in selection media. After an additional four weeks of selection (seven weeks
in total), all parasitophorous vacuoles (PVs) were exhibiting green fluorescence as shown
in Figure 4.1B (bottom row). The transgenic line of parasites stably expressing GFP is
hereinafter referred to as TetRGFP.

Figure 4.1. Generation of a GFP-expressing transgenic strain of T. gondii.
A. Schematic illustration of the strategy used to integrate GFP into the genome of TetR
strain via random insertion. A plasmid carrying GFP coding sequence and DHFR
selectable marker was transfected into TetR strain of T. gondii, followed by multiple
rounds of selection and dilution cloning.
B. Representative images of TetR strain transfected with pTUBGFP-DHFR plasmid at
different stages of selection. At three weeks of selection, majority of the PVs were
fluorescing green with the exception of a few vacuoles. After dilution cloning and a total
of seven weeks of selection, all parasites were stably expressing GFP as demonstrated by
the green fluorescing vacuoles in the bottom row.

Before the CRISPRi system can be tested in T. gondii, the integration of the
exogenous reporter gene GFP into the parasite’s genome via random insertion must be
confirmed. In addition to detecting green fluorescence from the PVs using fluorescence
microscopy, genomic DNA extracted from the parental strain (TetR) and the transgenic
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line of parasites (TetRGFP) were PCR amplified using a pair of primers complementary
to the GFP coding sequence to detect presence of GFP in the genomic DNA. Presence of
GFP is characterized by a thick band with size of approximately 747 bp in the PCR
products. In the lane containing PCR products generated from amplification reaction with
TetR genomic DNA as the template (Figure 4.2), a faint band of roughly 747 bp was
observed amongst bands of various sizes. In the lane containing PCR products generated
from amplification reaction with TetRGFP genomic DNA as the template (Figure 4.2), a
thick and bright band of roughly 747 bp was detected.

Figure 4.2. PCR detection of GFP in TetR (parental) and TetRGFP (transgenic) genome.
PCR reaction was employed to detect presence of GFP in the genomic DNA of TetR and
TetRGFP strain of T. gondii. Each lane consisted of PCR products generated from the
amplification reaction with genomic DNA from different strains as templates. The band
sizes of the 10 kb DNA ladder at the first lane are indicated on the left side of the image.
The band size of GFP is 747 bp, and presence of this band in the PCR product is
indicative of GFP presence in the template.
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4.4.2. Determining Optimal Time to Induce dCas9-KRAB Transcription
To determine the optimal time to induce dCas9-KRAB transcription without
compromising parasite viability, the following induction time points were examined: 0
hour and 16 hours upon infection of the monolayer. The transgenic GFP-expressing
parasite was first transfected with plasmid containing tetracycline-inducible dCas9KRAB and the single guide RNA named mycGFP-sg1, which targets the promoter region
81 bases upstream of the transcription start site (TSS) (Figure 4.3, Figure 4.4). The
transfected parasites were subsequently added to HFFs to infect their hosts, and ATc was
added either 0 hours or 16 hours post infection to induce transcription of dCas9 (Figure
4.4). Fluorescence images of mycGFP-sg1-dCas9 transfected TetRGFP parasites induced
with ATc 0 hour or 16 hours after infecting the HFF monolayer were taken for
fluorescence intensity analysis. From the fluorescence images shown in Figure 4.5 and
the relative mean vacuole fluorescence intensity plot shown in Figure 4.6, parasites that
were induced (+ATc) 0 hours post-infection exhibited approximately 8% lower average
fluorescence intensity compared to the control sample (-ATc) but the difference is not
statistically significant. A similar but more pronounced phenomenon was observed in
parasites that were induced with ATc 16 hours post-infection, where they exhibited
53.6% lower fluorescence intensity compared to the control. A notable difference
between parasites induced 0 hours post-infection and parasites induced 16 hours postinfection is the sizes of the PVs. From the violin plot shown in Figure 4.7, parasites
induced with ATc yielded in smaller vacuoles compared to the control. For parasites that
were ATc-induced 0 hours post-infection, majority of the vacuoles formed are
approximately 30 μm2 while vacuoles formed from parasites that were not induced with
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ATc are mostly 60-100 μm2 in size. For parasites that were ATc-induced 16 hours postinfection, there is a wider distribution of vacuole sizes with majority of the vacuoles
falling in the range of 70-200 μm2 while vacuoles formed from uninduced parasites are
around 100-400 μm2 in size. For both induction times, there is a two-fold difference in
average vacuole sizes between the induced and non-induced samples. Despite keeping the
parasite load consistent for all treatments, parasites in the 0 hour post-infection group
yielded in much smaller vacuoles than parasites in the 16 hour post-infection group
regardless of whether ATc was added or not. As a result, subsequent inductions of dCas9KRAB transcription were performed 16 hours after parasites have infected the HFF
monolayer.

Figure 4.3. Schematic illustration of locations and strands targeted by single guide RNAs
designed for this study. mycGFP-sg1 sgRNA targets the template strand of the TUB8
promoter region at position -81 to -62, mycGFP-sg2 sgRNA targets the nontemplate
strand of the mycGFP coding sequence near the start coding at position +295 to +314,
and mycGFP-sg3 sgRNA targets the template strand of the mycGFP coding sequence at
position +565 to +584. TSS represents transcription start site and the start codon is
denoted as ATG.

133

Figure 4.4. Generating an inducible CRISPRi system to repress gene expression in T.
gondii.
A. Schematic illustration of the plasmid construct containing the sgRNA mycGFP-sg1
and the dCas9 fusion protein coding sequence under the control of a tetracycline operator
(tetO). Transfection of said plasmid into tetracycline repressor-expressing strain of T.
gondii results in binding of the repressor to tetO and thus preventing dCas9-KRAB
transcription.
B. Flowchart outlining effects of inducer on dCas9-KRAB and GFP expression. No
induction of dCas9 transcription results in decreased dCas9 expression, which in turn
does not repress GFP transcription. The opposite occurs with induction of dCas9-KRAB
transcription, resulting in increased dCas9-KRAB expression and repression of GFP
transcription.

134

Figure 4.5. Representative images of parasites induced with anhydrotetracycline (ATc) at
two different time points post-infection. Coverslips containing HFF monolayers were
first infected with TetRGFP strain of parasites that were already transfected with 50 μg of
mycGFP1-dCas9 plasmid, then 3.0 μg/mL ATc was added either immediately (0 hours)
post-infection or 16 hours post-infection. Infected coverslips were fixed 24 hours after
induction and nuclear-stained with Hoechst. The same process is repeated but without the
inducer (-ATc) to serve as controls. Scale bars represent 25 μm.
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Figure 4.6. Relative average fluorescence intensity of parasitophorous vacuoles with
different induction times. Individual PV for each treatment was quantified for
fluorescence intensity using ImageJ software, and the average intensity values for the
+ATc samples are normalized to the control (-ATc samples). Error bars represent S.E.M
(n = 23). * indicates p < 0.05 compared to the no inducer control, unpaired two sample ttest.
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Figure 4.7. Size distribution of parasitophorous vacuoles with different induction times.
Individual PV for each treatment was quantified for its size using ImageJ software, and
the data distribution is presented as a violin plot using PlotsOfData software. Open circles
represent median of the data.

4.4.3. Determining Optimal Concentration of ATc for Inducing dCas9
Transcription
While parasites induced with ATc 16 hours post-infection had larger vacuole
sizes compared to parasites induced with ATc 0 hours post-infection (Figure 4.7), ATctreated parasites produced smaller vacuoles than the DMSO-treated parasites, indicating
that ATc has an effect on parasite viability at concentrations of 3.0 μg/mL. To find an
optimal concentration of ATc to induce transcription of dCas9-KRAB without
compromising parasite viability, the fluorescence intensities and vacuole sizes of
parasites treated with five different ATc concentrations, 0.25, 0.50, 1.0, 2.0, and 3.0
μg/mL, were examined and compared to the uninduced sample. From the relative mean
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fluorescence intensity plot shown in Figure 4.8, 0.25 μg/mL ATc group exhibited the
same fluorescence intensity as the control group (0 μg/mL). Unexpectedly, vacuoles
treated with 0.50 μg/mL ATc exhibited approximately 20% higher average fluorescence
intensity than the control, a difference that is statistically significant. However, vacuoles
treated with ATc concentration ≥ 1.0 μg/mL overall exhibited lower fluorescence
intensities and appeared to decrease with increasing ATc concentration. The 1.0 μg/mL
ATc group has an average fluorescence intensity 2% lower than the control, which is not
significantly different from the uninduced sample. Both the 2.0 and 3.0 μg/mL ATc
groups have slightly lower but statistically significant average fluorescence intensity; 2.0
μg/mL and 3.0 μg/mL ATc groups exhibited 8.2% and 15.5% lower fluorescence
intensity compared to the control respectively. A similar pattern is also observed in
vacuole sizes of parasites treated with the different ATc concentrations. The average
vacuole sizes of the 0.25 and 0.50 μg/mL ATc groups are no less than 10% smaller than
the control and do not differ significantly compared to the uninduced sample (Figure 4.9).
The difference in vacuole sizes is much more pronounced in samples treated with ≥ 1.0
μg/mL ATc. Average vacuole sizes of 1.0, 2.0, and 3.0 μg/mL ATc groups are only 62%,
45%, and 37% of the control sample’s average vacuole size respectively. Upon closer
examination of vacuole size distributions (Figure 4.10), the size range that majority of
the vacuoles fall under were relatively consistent for ATc concentrations less than 1.0
μg/mL but decreases with increasing ATc concentrations for samples treated with ≥ 1.0
μg/mL ATc. 80% of the vacuoles in the 0.25 μg/mL and 0.50 μg/mL ATc groups are 20700 μm2 in size, which is the range which majority of the vacuoles from the uninduced
group fall under. However, 80% of the vacuoles in 1.0 μg/mL, 2.0 μg/mL, and 3.0 μg/mL
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ATc groups are 10-400 μm2, 5-250 μm2, and 5-200 μm2 in size. These data collectively
indicated that ATc concentrations above 1.0 μg/mL have a significant effect on vacuole
sizes, while ATc concentrations below 1.0 μg/mL do not impact vacuole sizes.

Figure 4.8. Relative average fluorescence intensities of parasitophorous vacuoles
induced with different concentrations of ATc. Individual PV for each treatment was
quantified for fluorescence intensity using CellProfiler software, and the average
intensity values for the samples induced with different ATc concentrations are
normalized to the control (0 μg/mL ATc). Error bars represent S.E.M (n = 711). *
indicates p < 0.05 compared to the no inducer control, unpaired two sample t-test.
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Figure 4.9. Average parasitophorous vacuole sizes with different inducer concentrations.
Individual PV for each treatment was quantified for size using CellProfiler and average
vacuole sizes in μm2 are plotted as bar graphs. Error bars represent S.E.M (n = 710). *
indicates p < 0.05 compared to the no inducer control, unpaired two sample t-test.
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Figure 4.10. Size distribution of parasitophorous vacuoles with different inducer
concentrations. Individual PV for each treatment was quantified for size using
CellProfiler, and the data distribution is presented as a violin plot using PlotsOfData
software. Open circles represent median of the data (n = 710). * indicates p < 0.05
compared to the no inducer control, unpaired two sample t-test.

4.4.4. Comparing Different Single Guide RNA Constructs and Their Effects on
CRISPRi-mediated repression of GFP expression
One major factor that may influence the efficiency of CRISPRi-mediate gene
repression is the location and strand targeted by the single guide RNAs. Two additional
single guide RNA constructs named mycGFP-sg2 and mycGFP-sg3 were subsequently
designed to test and compare with the first sgRNA construct mycGFP1 in their abilities in
repressing GFP expression. mycGFP-sg2 is designed to target the nontemplate strand of
the beginning of the mycGFP coding sequence that is 295 bases downstream of TSS, and
mycGFP-sg3 is designed to target the middle of the mycGFP coding sequence that is 565
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bases downstream of TSS (Figure 4.3). Three different concentrations of the inducer
were also tested on the new single guide RNAs. As determined from the previous
experiment, the average vacuole fluorescence intensity was the lowest at 3.0 μg/mL ATc
for parasites transfected with the sgRNA mycGFP-sg1. However, this effect was not
observed in parasites transfected with sgRNA mycGFP-sg2 and mycGFP-sg3 (Figure
4.11). Both mycGFP-sg2 and mycGFP-sg3 groups induced with 3.0 μg/mL ATc yielded
in average fluorescence intensity values 8-9% higher than the control. While the average
vacuole fluorescence intensity of mycGFP-sg1-transfected parasites treated with 0.25 and
1.0 μg/mL were not different from the uninduced sample, the same phenomenon was not
observed with the other sgRNAs. mycGFP-sg2 and -sg3-transfected parasites treated with
0.25 μg/mL ATc also exhibited statistically higher average fluorescence intensities that
were approximately 5% higher than the control, but the difference is not as pronounced
as the 3.0 μg/mL ATc treatment. The 1.0 μg/mL ATc treatment, on the contrary, resulted
in 3-4% lower average vacuole fluorescence intensities for the parasites transfected with
mycGFP-sg2 and mycGFP-sg3.
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Figure 4.11. Relative average fluorescence intensities of parasitophorous vacuoles
transfected with different single guide RNAs and induced with different concentrations of
ATc. Individual PV for each treatment was quantified for fluorescence intensity using
CellProfiler software, and the average intensity values for the samples induced with
different ATc concentrations are normalized to the control (0 μg/mL ATc). Error bars
represent S.E.M (n = 625). * indicates p < 0.05 compared to the no inducer control,
unpaired two sample t-test.

4.5. Discussion
The CRISPR/Cas9 system is widely used as a genome editing tool in a number of
organisms, including the parasitic protozoan Toxoplasma gondii. This technology was
repurposed for sequence-specific control of gene expression and referred to as CRISPR
interference (CRISPRi). CRISPRi has been extensively used for loss-of-function studies
in a variety of organisms ranging from mammalian cells to bacteria to eukaryotic
parasites such P. falciparum, but it has yet to be established in T. gondii thus far (Gilbert
et al., 2013; Hawkins et al., 2015; Barcons-Simon et al., 2020). The very first step in
testing the CRISPRi system in the parasites was to decide on the gene of interest that will
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be targeted for gene repression. To easily determine whether the CRISPRi system was
facilitating the knockdown of a gene, GFP was chosen as the target gene recognized by
the single guide RNA in this experiment as its expression can be directly observed by its
fluorescence. Myc-tagged GFP along with the selectable marker DHFR was introduced
into the parasites together in the form of a plasmid and incorporated into the genome via
NHEJ. Successful cloning of the plasmid was confirmed by restriction digests and gel
electrophoresis. Upon complete construction and verification of the plasmid containing
the reporter gene and selectable marker, it was introduced into the TetR strain of T.
gondii and went through multiple rounds of selection in pyrimethamine media. After
three weeks of selection, most of the PVs observed using fluorescence microscopy were
green with the exception of a few vacuoles as illustrated in Figure 4.1. Theoretically,
parasites that did not take up or incorporate the pTUBGFP-DHFR plasmid into their
genome would not be able to survive in the presence of pyrimethamine. Thus, ideally all
parasites that survived numerous rounds of pyrimethamine selection should all be
expressing GFP and exhibit green fluorescence as well. Parasites that survived multiple
rounds of pyrimethamine selection but did not express GFP is likely due to degradation
of GFP’s transcript but not DHFR’s. When the plasmid is electroporated into the
parasites, the plasmid is linearized by double stranded breaks and may be broken into
smaller fragments; the fragment containing the GFP coding sequence and its promoter
may be degraded by DNases in the cytosol before it reaches the nucleus, while the
fragment containing the DHFR gene and its promoter safely arrives at the nucleus and
gets incorporated into the genome. The double stranded breaks in the plasmid may also
occur somewhere in the promoter or the coding sequence region purely by chance, thus
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disrupting the transcriptional unit as a whole and renders it unable to be transcribed even
if it arrives at the nucleus. Dilution cloning was then employed to exclude these nonfluorescing parasites and generate a clonal line of transgenic T. gondii that expresses GFP.
PCR analysis was done to ensure proper incorporation of GFP into electroporated
parasites’ genome. Primers flanking the GFP coding sequence were used to detect
presence of GFP in genomic DNA extracted from the transgenic strain (TetRGFP) and
also the parental strain (TetR) of T. gondii. The results from the PCR reactions shown in
Figure 4.2 confirmed incorporation of GFP in the transgenic line of the parasites. It is
worthy to note a faint band the same size as GFP was also detected in the parental strain’s
genomic DNA along with multiple bands of different sizes, which may be due to a
number of factors such as high template concentration or low annealing temperature
(Rychlik et al., 1990). However, this PCR reaction is still good confirmation of
successful incorporation of GFP into T. gondii, as considerably more products with the
size of GFP were generated from the amplification reaction with the transgenic parasites’
genomic DNA as the template.
After establishment of the transgenic line of parasites expressing GFP, the
plasmid containing the single guide RNA mycGFP-sg1 targeting the promoter region of
the mycGFP gene and the dCas9 protein fused to the KRAB repressor domain was
assembled by PCR amplifying the two components and cloning them into a vector system
(Figure 4.3, Figure 4.4). With the inducible CRISPRi system constructed and the
transgenic line of T. gondii established, 50 μg of the plasmid was introduced into the
parasites via electroporation to observe for reduced GFP expression and evaluate the
system’s efficiency when different parameters are altered. The first parameter examined
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was time of induction, where ATc was added to parasite-infected HFF monolayers at two
different time points post-infection. The fluorescence intensities of induced samples were
compared to uninduced samples which served as controls, and vacuole sizes were also
examined as a means to assess parasite viability. As shown in Figure 4.5 and Figure 4.6,
Parasites induced 16 hours post-infection exhibited significantly less average
fluorescence intensity compared to the uninduced control, while parasites induced 0
hours post-infection exhibited very little difference in fluorescence intensity compared to
the uninduced control. These results collectively demonstrated that 1) the CRISPRi
system designed was able to facilitate repression of GFP expression, and 2) inducing
dCas9-KRAB transcription 16 hours post-infection elicit a significantly greater
repression of GFP expression compared to 0 hours post-infection. Another distinct
difference between the two treatments is the size of PVs. The vacuoles of parasites
induced 16 hour post-infection are 2-6 times larger than the vacuoles of parasites induced
0 hours post-infection (Figure 4.7), but the induced parasites for both time points
generated vacuoles 2 times smaller than the uninduced sample. Significantly less
vacuoles were also observed in parasites induced 0 hours post-infection compared to the
uninduced control (Figure 4.5, Figure 4.7). These results indicated that ATc at a
concentration of 3.0 μg/mL interferes with the growth and viability of the parasites, and
this effect is especially pronounced when ATc is added directly after HFF infection.
Since GFP is a non-essential gene for parasite survival and growth, its repression via
CRISPRi likely would not contribute to reduced viability of ATc-treated parasites. ATc
and other derivatives of tetracycline exhibit certain degrees of anti-toxoplasmodial effect,
and thus the presence of ATc in the media would more or less affect the viability of the
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parasites (Chang et al., 1990). The parasites are also under stress when they are in the
extracellular environment prior to invading the host cells, and so the addition of
anhydrotetracycline into the media immediately after infecting the HFF monolayer with T.
gondii would likely kill the parasites before they can even reach the host cells (Lirussi &
Matrajt, 2011). Since a more pronounced gene repression effect was observed in parasites
induced with ATc 16 hours post-infection without significantly compromising parasite
viability, this induction time was used for subsequent experiments.
Following the previous experiment, various concentrations of ATc were examined
for their effects on repression of gene expression and parasite viability. Five different
ATc concentrations (0.25, 0.5, 1.0, 2.0, and 3.0 μg/mL) were tested on parasites
transfected with mycGFP-sg1-dCas9 plasmid (Figure 4.8). No discernable difference in
average vacuole fluorescence intensities compared to the uninduced sample was observed
at 0.25 μg/mL ATc, while an increase in fluorescence intensity was observed at 0.5
μg/mL. An inverse correlation between ATc concentration and fluorescence intensity was
observed in parasites induced with ≥1.0 μg/mL ATc — the higher the ATc concentration
used to induce dCas9 transcription, the lower the average fluorescence intensity of the
vacuoles. However, the repression effect is quite minimal as 1.0 μg/mL ATc-treated
parasites still exhibited 98% of the control’s fluorescence intensity, and 2.0 μg/mL ATctreated parasites exhibited 91.8% of the control’s fluorescence intensity. The highest
concentration, 3.0 μg/mL, exhibited 84.5% of fluorescence intensity relative to the
uninduced sample, which is more than 30% higher than what was observed in the
previous experiment with the same exact condition (Figure 4.8, Figure 4.6). The
discrepancy in average fluorescence intensities between the induction time experiment
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(Figure 4.6) and this experiment (Figure 4.8) could be attributed to the small sample size
for the induction time experiment, where only 23 vacuoles were examined compared to
711 vacuoles examined for this experiment. 84.5% fluorescence intensity relative to the
control is a more accurate depiction of the average intensity value for parasites induced
with 3.0 μg/mL ATc, as this value is generated from incorporation of data points from
two replicate experiments. These results indicate the following: 1) parasites induced with
ATc concentrations below 1.0 μg/mL did not have a marked effect in decreasing GFP
expression which suggests that at least 1.0 μg/mL ATc is required to induce dCas9
transcription, and 2) increasing ATc concentration above 1.0 μg/mL is associated with
increased GFP expression repression. A similar trend is also observed in PV sizes, where
parasites induced with ATc concentrations below 1.0 μg/mL have vacuoles that are
around the same size as the uninduced control, while decreasing vacuole sizes with
increasing ATc concentrations was observed in parasites induced with ATc
concentrations ≥ 1.0 μg/mL (Figure 4.9, Figure 4.10). This indicates ATc concentrations
below 1.0 μg/mL do not significantly impact parasite growth and viability, while
concentrations equal or above 1.0 μg/mL may impede growth of parasites or are lethal to
certain extent. It is worthwhile to note that the reduction in GFP expression observed may
not be entirely attributed to CRISPRi activity but rather as a result of global protein
synthesis inhibition by high levels of ATc. The effect of various ATc concentrations on
GFP expression in absence of the minimal CRISPRi system should be investigated
further to solidify current findings.
The single guide RNA is an essential component of any CRISPR-based
techniques, so it is not surprising that the efficiency at which CRISPRi facilitate
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repression of the gene of interest can be influenced by or are reliant on properties of the
sgRNA. Multiple studies have alluded to the importance of single guide RNA sequence,
length, and target position (Gilbert et al., 2014; Radzisheuskaya et al., 2016). To
determine whether the lack of significant repression of GFP expression was dependent on
the sgRNA (mycGFP-sg1) used for previous studies and to test if CRISPRi-mediated
repression of GFP expression could be improved, two additional sgRNA constructs were
designed and cloned into sgRNA expression vector (Figure 4.3). All three sgRNA
constructs were treated with three different ATc concentrations (0.25, 1.0, 3.0 μg/mL) to
compare the repression effects. The average vacuole fluorescence intensities values for
mycGFP-sg2/3 were distinctly different than the original sgRNA designed (mycGFP-sg1)
(Figure 4.11). At 0.25 μg/mL ATc concentration, mycGFP-sg2/3 exhibited higher
fluorescence intensities than mycGFP-sg1, which is about the same level of intensity as
the control as discussed previously. At 1.0 μg/mL ATc, mycGFP-sg2/3 exhibited slightly
lower but not statistically significant fluorescence intensities which is in congruence with
mycGFP-sg1. 3.0 μg/mL ATc-treated parasites transfected with mycGFP-sg1 have
consistently showed the lowest average fluorescence intensity compared to the other ATc
concentrations, but the opposite effect was observed in mycGFP-sg2/3-transfected
parasites which were characterized by higher fluorescence intensities than the control.
These results indicate that while 3.0 μg/mL ATc is able to induce a knockdown effect
when the sgRNA (mycGFP-sg1) is targeting the template strand of the promoter region, it
does not affect the expression of GFP when the sgRNAs (mycGFP-sg2/3) are targeting
the coding sequence. The elevated fluorescence intensities above the level of the control
observed in certain treatments throughout this study may be a result of high saturation of
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parasites within one vacuole thus giving the appearance of brighter vacuoles and higher
fluorescence intensities, or due to unknown factors that cause GFP expression to be
further upregulated. From the data collected, it is clear that sgRNAs mycGFP-sg2 and
mycGFP-sg3 were unable to improve gene repression effect mediated by CRISPRi.
Although the lengths of all three sgRNAs fall within the 18-21 base pair range that was
found to be optimal for CRISPRi, the maximal gene repression efficiency facilitated by
CRISPRi observed in this study is only about 15% (Gilbert et al., 2014). The lack of
significant reduction in gene expression demonstrated by all three sgRNA constructs may
be attributed to the location of the gene that they target. A study by Gilbert et al. (2014)
demonstrated sgRNAs that target DNA in the region of -50 to +300 relative to TSS
demonstrate strong CRISPRi activity, and the regions that the three sgRNAs targeted in
this study did not fall within that specified range but are still within the window where
certain degree of activity is exhibited. Although mycGFP-sg2 targets position +295 to
+314 relative to the TSS, which is quite close to the high activity range, no significant
reduction in fluorescence intensity compared to other sgRNAs was observed for any
concentrations of inducer. CRISPRi-mediated gene repression efficiency may be
improved by designing the sgRNA to target DNA within the +50 to +100 base pairs
downstream of the TSS for future studies, as maximal sgRNA activity was observed
within this narrow window (Gilbert et al., 2014). The target strand may also influence
CRISPRi efficiency, as a study by Qi et al. (2013) demonstrated that effective silencing
of the target gene is observed in sgRNAs that target the nontemplate strand of the coding
region and both the template and nontemplate strand of the promoter region, while little
silencing was observed in sgRNAs that target the template strand of the coding region.
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Theoretically, mycGFP-sg1 and mycGFP-sg2 would yield in higher repression of GFP
expression compared to mycGFP-sg3, since mycGFP-sg1 targets the template strand in
the promoter region and mycGFP-sg2 targets the nontemplate strand while mycGFP-sg3
targets the template strand of the coding region. However, such trend was not observed as
the three sgRNAs all exhibit little to no repression of GFP expression, which indicates
that CRISPRi silencing efficiency is not solely dependent on DNA strand targeted but is
likely determined by multitude of factors such as the position of the sgRNA relative to
the transcription start site that was discussed previously, as well as chromatin
accessibility of the target site, sgRNA length and sequence (Radzisheuskaya et al., 2016;
Xu et al., 2015). The lack of CRISPRi-mediated repression of gene expression observed
in this study could also be due to instability of the sgRNAs, as level of sgRNAs is a
major determinant of CRISPRi knockdown efficiency (Wang et al., 2021). Although the
sgRNAs in this study are under a strong U6 promoter which is commonly used to drive
high expression of small RNAs, and maximal quantity of plasmid DNA (50 μg) carrying
the sgRNA and dCas9 sequence were transfected to ensure their expression within the
parasite, great instability of sgRNA in the absence of dCas9 would still lead to lack of
gene silencing (Ma et al., 2016). Like the sgRNA, sufficient expression of dCas9-KRAB
is also required for efficient CRISPRi knockdown. A recent study by Wang et al. (2021)
demonstrated that the inducible dCas9-KRAB have a lower expression level than the
constitutively-expressed dCas9-KRAB, which may also help to explain the lack of
CRISPRi-mediated repression of GFP expression in this study. In addition to properties
of the sgRNA, different orthologs of Cas9 from other bacteria could also result in varying
silencing efficiencies in different organisms. For example, dCas9 derived from
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Streptococcus pyogenes is most commonly used in CRISPRi studies in a wide range of
organisms, but it was unable to facilitate repression of gene expression in Caulobacter
crescentus while dCas9 derived from Streptococcus thermophilus and Streptococcus
pasteurianus effectively silenced the gene of interest (Guzzo et al., 2020). Multiple
aspects of the CRISPRi components must be collectively considered in order to generate
a highly efficient repression system functional in T. gondii.

4.6. Conclusions and Future Directions
In summary, the results of this study showed that the inducible CRISPRi system
constructed and established in Toxoplasma gondii exhibited little to no silencing effect on
the gene of interest. It was determined that induction of dCas9-KRAB transcription with
ATc 16 hours after T. gondii infection generated better knockdown efficiency than 0
hours post-infection and does not significantly compromise parasite growth and viability.
ATc concentrations at or above 1.0 μg/mL is necessary to induce CRISPRi-mediated
gene repression of the target gene, as concentrations below 1.0 μg/mL ATc demonstrated
no effect on GFP silencing. The three sgRNAs used in this study were inefficient at
facilitating significant reduction in gene expression, which can be attributed to a
multitude of factors that dictate CRISPRi activity that must be carefully considered and
finely tuned to achieve maximal silencing effect. Further optimization is required for this
system to be used for loss-of-function studies.
Future directions with this project would be to modify the current implemented
CRISPRi system to improve its gene silencing efficiencies. First, dCas9 derived from
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other bacteria should be tested alongside the dCas9 used for this study, which is derived
from S. pyogenes, to find the enzyme that facilitate the highest silencing effect. Second,
new sgRNAs targeting the nontemplate strand of DNA within position +50 to +100
relative to the TSS should be constructed and tested alongside with current sgRNAs used
for this study. Once effective sgRNAs have been identified, it would be worthwhile to
test if multiple sgRNAs targeting different locations of the same gene would further
increase repression of gene expression as this has been demonstrated to be the case in a
study in Lactococcus lactis (Xiong et al., 2020). Third, it would be beneficial to create a
line of parasites that constitutively expresses high levels of dCas9-KRAB and sgRNA, as
a prerequisite for efficient CRISPRi silencing is to have sufficient amount of dCas9KRAB and sgRNA in the first place (Wang et al., 2021). Fourth, modifications that
stabilizes sgRNAs such as adding a 5’ cap and 3’ polyA tail should be done to ensure
efficient CRISPRi knockdown (Mu et al., 2019). Lastly, an alternative CRISPRi system
based on dCas12 can also be used if: 1) CRISPR/dCas9 system is ineffective, and 2) there
is a lack of Cas9 PAM sequence (NGG) within the target region, which may be the case
in AT-rich organisms such as T. gondii’s close relative P. falciparum, since Cas12 uses
PAM sequences enriched in T instead of G (Tang & Fu, 2018).
After successful establishment of an efficient CRISPRi system, it would be used
to study long non-coding RNAs (lncRNAs) in T. gondii as CRISPRi is able to facilitate
highly-specific perturbation of any lncRNA gene and is currently the most suitable
technique for studying lncRNA functions (Liu et al., 2017; Liu et al., 2021). One specific
lncRNA that would be of interest to study using CRISPRi is the natural antisense
transcript (TgUlp1-NAT) that regulates the gene encoding for ubiquitin-like protease 1
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(Ulp1) in T. gondii (Crater et al., 2018). Ulp1 is a key enzyme in the post-translational
regulatory pathway named SUMOylation, which is critical for parasite invasion and the
formation of protective cyst structures in its host cells. CRISPRi can be employed to
characterize and investigate the function of TgUlp1-NAT as a potential regulator of
SUMOylation by repressing TgUlp1-NAT expression and observe for changes in
viability and infectivity of T. gondii via viability assays. Investigation of TgUlp1-NAT
will allow us to gain a better understanding of the parasitic protozoan’s pathogenicity and
potentially lead to development of effective drugs against the prevalent infectious disease
caused by T. gondii.
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APPENDICES

TgSUMO

C-Term His Tag
T7 Term inator

GFP
Myc Tag
N-Term His Tag
RBS

KanR

T7 Prom oter

pET28-MHL MycGFP TgSUMO
6370 bp

Figure A1. Illustration of pET28-MHL MycGFP TgSUMO plasmid for Chapter 3.

C-Term His Tag
GFP

T7 Term inator

Myc Tag
N-Term His Tag
RBS
T7 Prom oter

KanR

pET28 MHL MycGFP (w/o SUMO)
6094 bp

Figure A2. Illustration of pET28-MHL MycGFP plasmid for Chapter 3.
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SUMO
ROP8 KD (L266-Y554)

C-Terminal His Tag
T7 Terminator

GFP

Myc Tag

KanR

N-Terminal His Tag
RBS

pET28 MHL MycGFP ROP8 KD TgSUMO
7237 bp

T7 Promoter

Figure A3. Illustration of pET28-MHL MycGFP ROP8 KD TgSUMO for Chapter 3.

F1 ORI
RP
AP r

RP
RP1
RP2
RP
gRNA annealing site

ColE1 ORI

pTUBMycGFP
6418 bp

Initiation site
Tub8
'5UTRTUB
myc epitope tag

P lac

GFP
SAG1 3'-UTR

TgHXGPRT cassette

TgHXGPRT

Figure A4. Illustration of pTUBGFPHX plasmid for Chapter 4.
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YFP
LICscreenRV
LIC cassette
Universal

DHFR cassette putative

pYFP-LIC-DHFR
8054 bp

Figure A5. Illustration of the pYFP.LIC.DHFR plasmid for Chapter 4.

Pol3 term inator
Cas9 recognition sequence

Tub1 prom oter

m ycGFP1 spacer

Flag tag

U6 upstream region (pol3 prom oter)

Am picillin Resistance (not precise)

pU6-mycGFP1
8379 bp

FLAG NLS Cas9

Figure A6. Illustration of the pU6-mycGFP-sg1 plasmid for Chapter 4.
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Figure A7. Illustration of the pAAVS1-NDi-CRISPRi (Gen 1) plasmid for Chapter 4.

Figure A8. Illustration of the pGEM-T Easy Vector plasmid for Chapter 4.

164

TetO
K RAB

Ampicillin R esistance

pGEM-T-Easy dCas9
8752 bp

dC as9

mC herry

SV40 N LS
SV40 N LS

Figure A9. Illustration of the pGEM-T-Easy dCas9 plasmid for Chapter 4.

Figure A10. Illustration of the pU6 Universal plasmid for Chapter 4.
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KRAB
TetO
dCas9

pGEM-T-Easy dCas9 PolyA
8937 bp

Ampicillin Resistance

mCherry
poly A signal

Figure A11. Illustration of the pGEM-T-Easy dCas9 plasmid for Chapter 4.

TetO

TUB promoter

KRAB

mycGFP1 spacer
U6 Promoter

mycGFP1-dCas9
9997 bp

dCas9

Ampicillin Resistance

poly(A) signal
mCherry

Figure A12. Illustration of the mycGFP-sg1-dCas9 plasmid for Chapter 4.
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Pol3 terminator
Cas9 recognition sequence
Guide or protospacer

Tub1 promoter

U6 upstream region (pol3 promoter)

pU6 (-) Cas9
3858 bp

Ampicillin Resistance (not precise)

Figure A13. Illustration of the pU6 (-) Cas9 plasmid for Chapter 4.

Pol3 terminator
Cas9 recognition sequence
mycGFP2 spacer

Tub1 promoter

U6 upstream region (pol3 promoter)

pU6 mycGFP2 (-) Cas9
3866 bp

Ampicillin Resistance (not precise)

Figure A14. Illustration of the pU6 mycGFP-sg2 (-) Cas9 plasmid for Chapter 4.

167

Pol3 terminator
Cas9 recognition sequence
mycGFP3 spacer

Tub1 promoter

U6 upstream region (pol3 promoter)

pU6 mycGFP3 (-) Cas9
3866 bp

Ampicillin Resistance (not precise)

Figure A15. Illustration of the pU6 mycGFP-sg3 (-) Cas9 plasmid for Chapter 4.

Tub1 promoter

tet O
KRAB

Ampicillin Resistance

pGEM-T-Easy-dCas9-PolyA-pTUB1
9403 bp

dCas9

poly A signal
mCherry

Figure A16. Illustration of the pGEM-T-Easy-dCas9-PolyA-pTUB1 plasmid for Chapter
4.

168

Tub1 promoter

tet O
KRAB

CAT

dCas9 (-) sgRNA CAT
10739 bp

dCas9

Ampicillin Resistance

poly A signal

mCherry

Figure A17. Illustration of the dCas9 (-) sgRNA CAT plasmid for Chapter 4.
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